0001185185-16-003641.txt : 20160210 0001185185-16-003641.hdr.sgml : 20160210 20160209190220 ACCESSION NUMBER: 0001185185-16-003641 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 45 CONFORMED PERIOD OF REPORT: 20151231 FILED AS OF DATE: 20160210 DATE AS OF CHANGE: 20160209 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMERITYRE CORP CENTRAL INDEX KEY: 0000945828 STANDARD INDUSTRIAL CLASSIFICATION: TIRES AND INNER TUBES [3011] IRS NUMBER: 870535207 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-50053 FILM NUMBER: 161401639 BUSINESS ADDRESS: STREET 1: 1501 INDUSTRIAL ROAD CITY: BOULDER CITY STATE: NV ZIP: 89005 BUSINESS PHONE: 7022931930 MAIL ADDRESS: STREET 1: 1501 INDUSTRIAL ROAD CITY: BOULDER CITY STATE: NV ZIP: 89005 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN TIRE CORP DATE OF NAME CHANGE: 19951117 10-Q 1 amerityre10q123115.htm 10-Q amerityre10q123115.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549  
 
 
FORM 10-Q  
 
 
(Mark One)
x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended:   December 31, 2015

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________________ to ____________________.
 
Commission file number: 000-50053
GRAPHIC
AMERITYRE CORPORATION
(Exact name of small business issuer as specified in its charter)

NEVADA
87-0535207
(State or other jurisdiction of
(I.R.S. Employer
incorporation or organization)
Identification No.)

1501 INDUSTRIAL ROAD, BOULDER CITY, NEVADA
89005
(Address of principal executive offices)
(Zip Code)

(702) 293-1930
(Issuer’s telephone number)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x   No o
  
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer  ¨      Accelerated filer  ¨      Non-accelerated filer  ¨      Smaller reporting company x
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes  ¨  No  x
 
The number of shares outstanding of Registrant’s Common Stock as of February 8, 2016: 41,950,287
 
 
TABLE OF CONTENTS

 
 
PART I - FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS
AMERITYRE CORPORATION
Balance Sheets
 
   
December 31,
2015
    
June 30,
2015
  
   
(Unaudited)
        
ASSETS
            
CURRENT ASSETS
            
Cash
  
$
156,288
    
$
455,717
  
Accounts receivable - net
    
312,891
      
314,054
  
Accounts receivable - related party
    
-
      
6,312
  
Inventory - net
    
646,012
      
661,129
  
Prepaid and other current assets
    
96,128
      
27,860
  
Total Current Assets
    
1,211,319
      
1,465,072
  
                 
PROPERTY AND EQUIPMENT
                
Leasehold improvements
    
153,543
      
153,543
  
Molds and models
    
572,894
      
572,894
  
Equipment
    
2,964,900
      
2,937,922
  
Furniture and fixtures
    
74,921
      
74,921
  
Software
    
305,924
      
305,924
  
Less - accumulated depreciation
    
(3,803,107
)
    
(3,735,744
)
Total Property and Equipment
    
269,075
      
309,460
  
                 
OTHER ASSETS
                
Patents and trademarks - net
    
189,045
      
202,710
  
Non-current inventory
    
195,778
      
186,560
  
Deposits
    
11,000
      
11,000
  
Total Other Assets
    
395,823
      
400,270
  
TOTAL ASSETS
  
$
1,876,217
    
$
2,174,802
  
             
LIABILITIES AND STOCKHOLDER'S EQUITY
            
CURRENT LIABILITIES
            
Accounts payable and accrued expenses
  
$
438,664
    
$
438,680
  
Current portion of long-term debt
    
12,441
      
13,608
  
Current portion of lease liability
    
5,642
      
-
  
Total Current Liabilities
    
456,747
      
452,288
  
                 
Long-term debt
    
53,840
      
53,840
  
Long-term lease liability
    
11,677
      
-
  
Total Long-Term Liabilities
    
65,517
      
53,840
  
TOTAL LIABILITIES
    
522,264
      
506,128
  
                 
STOCKHOLDERS' EQUITY
                
Preferred stock: 5,000,000 shares authorized
of $0.001 par value, 2,000,000 shares issued and
outstanding, respectively
    
2,000
      
2,000
  
Common stock: 75,000,000 shares authorized of
$0.001 par value, 41,800,287 and 41,441,620 shares
Issued and outstanding, respectively
    
41,800
      
41,570
  
Additional paid-in capital
    
62,552,922
      
62,515,856
  
Stock payable
    
4,500
      
-
  
Accumulated deficit
    
(61,247,269
)
    
(60,890,752
)
Total Stockholders' Equity
    
1,353,953
      
1,668,674
  
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
  
$
1,876,217
    
$
2,174,802
  

The accompanying notes are an integral part of these financial statements.
 
 
AMERITYRE CORPORATION
Statements of Operations
(Unaudited)
 
   
For the Three Months Ended
December 31,
    
For the Six Months Ended
December 31,
  
   
2015
    
2014
    
2015
    
2014
  
                         
NET SALES
  
$
914,888
    
$
1,349,336
    
$
1,928,821
    
$
2,381,060
  
                                 
COST OF GOODS SOLD
    
696,671
      
1,035,209
      
1,463,447
      
1,836,865
  
                                 
GROSS PROFIT
    
218,217
      
314,127
      
465,374
      
544,195
  
                                 
EXPENSES
                                
Research and development
    
55,962
      
57,646
      
109,567
      
97,490
  
Sales and marketing
    
68,595
      
167,346
      
166,259
      
286,205
  
General and administrative
    
269,800
      
217,759
      
494,640
      
448,295
  
                                 
Total Expenses
    
394,357
      
442,751
      
770,466
      
831,990
  
                                 
LOSS FROM OPERATIONS
    
(176,140
)
    
(128,624
)
    
(305,092
)
    
(287,795
)
                                 
OTHER INCOME/(EXPENSE)
                                
Interest expense
    
(935
 )    
-
      
(1,534
 )    
-
  
Interest income
    
36
      
159
      
109
      
366
  
Total Other Income/(Expense)
    
(899
 )    
159
      
(1,425
 )    
366
  
                                 
NET LOSS
    
(177,039
)
    
(128,465
)
    
(306,517
)
    
(287,429
)
                                 
Preferred Stock Dividend
    
(25,000
)
    
(25,000
 )    
(50,000
)
    
(50,000
)
                                 
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS
  
$
(202,039
)
  
$
(153,465
)
  
$
(356,517
)
  
$
(337,429
)
                                 
BASIC AND DILUTED LOSS PER SHARE
  
$
(0.00
)
  
$
(0.00
)
  
$
(0.01
)
  
$
(0.01
)
                                 
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING
    
41,731,809
      
41,441,620
      
41,681,483
      
41,441,620
  
 
The accompanying notes are an integral part of these financial statements.
 
 
AMERITYRE CORPORATION
Statements of Cash Flows
(Unaudited)
 
   
For the Six Months Ended
December 31,
  
   
2015
    
2014
  
CASH FLOWS FROM OPERATING ACTIVITIES
            
Net loss
  
$
(306,517
)
  
$
(287,429
)
Adjustments to reconcile net loss to net cash used by operating activities:
                
Depreciation and amortization expense
    
81,028
      
90,627
  
Change in allowance for bad debt expense (recovery)
    
(289
)
    
(8,066
)
Stock paid for services
    
-
      
5,147
  
Stock based compensation related to consultant, employee and director options
    
41,795
      
13,571
  
Changes in operating assets and liabilities:
                
Accounts receivable
    
7,764
      
(110,633
)
Inventory and inventory reserve
    
 5,899
      
53,115
  
Prepaid and other current assets
    
(68,268
)
    
(29,015
)
Accounts payable and accrued expenses
    
(7,656
)
    
430
  
Net Cash Used by Operating Activities
    
(246,244
)
    
(272,253
)
CASH FLOWS FROM INVESTING ACTIVITIES
                
Purchase of property and equipment
    
-
      
(31,721
)
Net Cash Used by Investing Activities
    
-
      
(31,721
)
CASH FLOWS FROM FINANCING ACTIVITIES
                
Payments on lease liability
    
(2,018
)
    
-
  
Payments on notes payable
    
(1,167
)
    
(1,460
)
Preferred stock issuance costs
    
-
      
(188
)
Preferred stock dividends
    
(50,000
)
    
(50,000
)
Net Cash (Used) by Financing Activities
    
(53,185
)
    
  (51,648
) 
NET DECREASE IN CASH
    
(299,429
)
    
(355,622
)
CASH AT BEGINNING OF PERIOD
    
455,717
      
728,585
  
CASH AT END OF PERIOD
  
$
156,288
    
$
372,963
  
 
SUPPLEMENTAL SCHEDULE OF CASH FLOW ACTIVITIES
                
                 
Interest paid
  
$
1,534
    
$
-
  
Income taxes paid
  
$
 -
    
$
 -
  
                 
NON-CASH INVESTING AND FINANCING ACTIVITIES
                
                 
Capitalized lease
  
$
19,337
    
$
 -
  
Reclassification of accounts receivable – related party to accounts receivable
  
$
6,312
    
$
 -
  
Equipment purchase accrued for, not paid in cash
  
$
7,641
    
$
-
  

The accompanying notes are an integral part of these financial statements.
 
 
AMERITYRE CORPORATION
Notes to the Unaudited Financial Statements
December 31, 2015
 
NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION
 
The accompanying unaudited condensed financial statements have been prepared by us pursuant to the rules and regulations of the Securities and Exchange Commission.  Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted in accordance with such rules and regulations.  The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements.  We believe the disclosures and information presented are adequate to make the information not misleading.  These interim condensed financial statements should be read in conjunction with our most recent audited financial statements and notes thereto included in our June 30, 2015 Annual Report on Form 10-K.  Operating results for the six months ended December 31, 2015 are not necessarily indicative of the results that may be expected for the current fiscal year ending June 30, 2016.
 
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 
Significant accounting policies disclosed therein have not changed since our audited financial statements and notes thereto included in our June 30, 2015 Annual Report on Form 10-K, except as noted below.

Reclassifications

Certain reclassifications, which have no effect on net loss, have been made in the prior period financial statements, specifically the recognition of the preferred share dividend as a non-cash transaction at December 31, 2014.
 
Trade Receivables
 
We generally charge-off trade receivables that are more than 120 days outstanding as bad-debt expense, unless management believes the amount to be collectable. The charge-off amounts are included in general and administrative expenses. As of December 31, 2015 and 2014, the reserve for uncollectible accounts was $-0- and $7,296, respectively.
 
Stock Based-Compensation Expense
 
We account for stock-based compensation under the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 718, Compensation – Stock Compensation (ASC 718).  Our financial statements as of and for the quarters ended December 31, 2015 and 2014 reflect the impact of ASC 718.  Stock-based compensation expense related to director, employee or consultant options recognized under ASC 718 for the six months ended December 31, 2015 and 2014 was $41,795 and $13,571, respectively.
 
ASC 718 requires companies to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model.  The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in our Statement of Operations.  Stock-based compensation expense recognized in our Statements of Operations for the six months ended December 31, 2015 and 2014 assumes all awards will vest; therefore no reduction has been made for estimated forfeitures.  We have awarded some options with a performance requirement and no amounts will be recorded until the requirement is met.

Basic and Fully Diluted Net Loss Per Share
 
Basic and Fully Diluted net loss per share is computed using the weighted-average number of common shares outstanding during the period.
 
Our outstanding stock options and warrants and shares issuable upon conversion of outstanding convertible notes have been excluded from the basic and fully diluted net loss per share calculation.  We excluded 3,700,000 and 2,834,000 common stock equivalents for the six months ended December 31, 2015 and 2014, respectively, because they are anti-dilutive.
 
 
AMERITYRE CORPORATION
Notes to the Unaudited Financial Statements
December 31, 2015
 
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Continued
 
Recent Accounting Pronouncements

Recently Adopted and Recently Issued Accounting Guidance

Issued

In January 2015, the FASB issued ASU 2015-01, “Income Statement – Extraordinary and Unusual Items (Subtopic 225-20),” which eliminates the concept of extraordinary items. The new guidance is effective for fiscal years and interim periods within those years beginning after December 15, 2015. The new guidance is to be applied prospectively but may also be applied retrospectively to all prior periods presented in the financial statements. Early adoption is permitted provided that the guidance is applied from the beginning of the fiscal year of adoption. We expect to adopt the provisions of this new guidance on July 1, 2016. We do not expect the adoption of the new provisions to have a material impact on our financial condition or results of operations.

In November 2015, the FASB issued ASU No. 2015-17, “Balance Sheet Classification of Deferred Taxes,” requiring all deferred tax assets and liabilities, and any related valuation allowance, to be classified as noncurrent on the balance sheet. The classification change for all deferred taxes as noncurrent simplifies entities’ processes as it eliminates the need to separately identify the net current and net noncurrent deferred tax asset or liability in each jurisdiction and allocate valuation allowances. We do not expect the adoption of the new provisions to have a material impact on our financial condition or results of operations.

In July 2015, the FASB issued ASU No. 2015-11, “Simplifying the Measurement of Inventory”. Under ASU 2015-11, inventory will be measured at the “lower of cost and net realizable value” and options that currently exist for “market value” will be eliminated. The standard defines net realizable value as the “estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.” No other changes were made to the current guidance on inventory measurement. ASU 2015-11 is effective for interim and annual periods beginning after December 15, 2016. Early application is permitted and should be applied prospectively. The Company is currently evaluating the impact the adoption of ASU 2015-11 will have on its financial statements.

Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the SEC, did not, or are not believed by management to, have a material impact on the Company's present or future financial position, results of operations or cash flows.

Related Party Transactions
 
Amerityre’s immediate past Chairman of the Board, Timothy L. Ryan, is also the principal owner of Rhino Rubber LLC, a manufacturing and distribution company for solid industrial tires and wheels.  As of December 31, 2015, Mr. Ryan is no longer a director of the Company and all receivables outstanding to Rhino Rubber LLC have been reflected as trade accounts receivable.
 
We currently distribute directly from our manufacturing facility in Boulder City, Nevada only.  In the past we also distributed from an independent, contracted warehouse in Ravenna, Ohio.  This contract distribution point was unable to support customer requirements, became ineffective and stopped operations in the second quarter of 2014.  In order to keep commitments to customers and keep revenue growth positive, distribution and other related services were transferred to Rhino Rubber in Akron, Ohio.  The Company paid $600 for monthly warehousing fees inclusive of freight, shipping and labor for mounting services through October 31, 2015.  Effective October 31, 2015 we closed the Akron, Ohio distribution point and customers are serviced on a direct basis.
 
 
AMERITYRE CORPORATION
Notes to the Unaudited Financial Statements
December 31, 2015
 
NOTE 3 - INVENTORY

Inventory is stated at the lower of cost (computed on a first-in, first-out basis) or net realizable value.  The inventory consists primarily of chemicals, finished goods produced in our plant and products purchased for resale.
 
   
December 31, 2015
    
June 30, 2015
  
   
(Unaudited)
        
Raw Materials
  
$
272,689
    
$
302,910
  
Finished Goods
    
695,243
      
655,714
  
Inventory reserve
    
(126,142
)
    
(110,935
)
Inventory - net
  
$
841,790
      
847,689
  
 
Our inventory reserve reflects items that were deemed to be slow moving or obsolete based on an analysis of all inventories on hand.

The Company critically reviews all slow moving inventory to determine if defective or obsolete.  If not defective or obsolete, but slow moving, we present these items as non-current inventory, although all inventory is ready and available for sale at any moment.  

NOTE 4 - CAPITAL LEASE

In July 2015 the Company entered into a capital lease for research and development equipment for $19,337.

The following is a schedule by years of future minimum lease payments under capital leases together with present value of the net minimum lease payments as of December 31, 2015:

2016
   $ 4,349  
2017
     8,697  
2018
     8,697  
2019
     725  
2020
     -  
Total minimum lease payments
     22,468  
Less:  executory costs
     -  
Net minimum lease payments
     22,468  
Less:  amount representing interest
     5,149  
Present value of net minimum payments
   $ 17,319  

NOTE 5 - STOCK TRANSACTIONS
 
In July 2015 the Board of Directors granted the following stock bonus awards:
 
·  
To all non-officer employees of Amerityre on record as of July 22, 2015, a one-time stock bonus award of 5,000 shares of the Company’s restricted common stock per employee, valued at $0.015 a share (fair value on the date of grant with a 50% discount pursuant to U.S. Internal Revenue Service, revenue Ruling 77-287).  As of July 22, 2015 there were 16 non-officer employees at Amerityre resulting in 80,000 shares, which were issued in July 2015.

·  
To the officers of Amerityre, 600,000 shares were granted on July 20, 2015 (valued at $0.03) with 75% of the grant allocated to the CEO and 25% of the grant allocated to the CFO.  The shares of stock vest ratably each quarter end during fiscal year 2016 and are payable immediately after the vesting date.  For the six months ended December 31, 2015 the Company recognized $9,000 of compensation expense for these grants; $4,500 of which is a stock payable.

 
AMERITYRE CORPORATION
Notes to the Unaudited Financial Statements
December 31, 2015
 
NOTE 6 - STOCK OPTIONS AND WARRANTS

General Option Information

On July 6, 2011, the Board of Directors cancelled the “2004 Non-Employee Directors’ Stock Incentive Plan” and approved the "Directors’ 2011 Stock Option and Award Plan”.   Under the 2011 Plan, a total of 3,300,000 shares are authorized for issuance.

The Company also maintained the 2005 Stock Option and Award Plan, which was previously approved by shareholders, for the purpose of granting option awards to its employees and consultants.   This plan had a 10 year life and expired July 2015.
 
On August 10, 2015, the Board of Directors cancelled the “Directors’ 2011 Stock Option and Award Plan” as all options under this plan had been granted and adopted the “2015 Omnibus Stock Option and Award Plan” which contains provisions for up to 3,000,000 stock options to be granted to employees, consultants and directors.  The 2015 Omnibus Stock Option and Award Plan did not obtain the necessary shareholder approval in the Company’s annual proxy process, resulting in certain U.S. Internal Revenue Service provisions to be ineffective.

Option issuances and vesting during the six month period ending December 31, 2015

On December 1, 2014, 480,000 options were granted to the Company’s Chief Executive Officer (then our Chief Operating Officer) as part of his employment offer.  The options have a strike price of $0.10, vest December 1, 2015 and expire December 1, 2020.  Year to date expense related to these options is $7,746 as of December 31, 2015. 

On January 21, 2015, 50,000 options were granted to the Company’s Chief Financial Officer as part of her employment offer.  The options have a strike price of $0.10, vest ratably January 21, 2015 to December 1, 2015 and expire December 1, 2018.  Year to date expense related to these options is $840 as of December 31, 2015.

In the October 2015 Board meeting, the Board granted all non-executive Board members 100,000 options, with the audit committee chair receiving an additional 50,000 options, for Board services rendered for the fiscal year ended June 30, 2015.  The options have a strike price of $0.10, vest at the end of the Board term on December 3, 2015 and expire December 3, 2017.  Expense related to these options is $21,950 as of December 31, 2015.

On December 1, 2015, 480,000 options were granted to the Company’s Chief Executive Officer (then our Chief Operating Officer) as part of his employment offer.  The options have a strike price of $0.10, vest December 1, 2016 and expire December 1, 2020.  Year to date expense related to these options is $1,060 as of December 31, 2015. 

As of December 31, 2015, there was $11,655 of unrecognized stock-based compensation expense related to stock options that will be recognized over the vest period of the underlying option.

We estimated the fair value of the stock options above at the grant date based on the following weighted average assumptions:
 
Risk free interest rate
     1.155
% 
Expected life
     2.0 – 4.5
 years 
Expected volatility
     167.37 – 113.50
% 
Dividend yield
     0.00
% 
 
A summary of the status of our outstanding stock options as of December 31, 2015 and June 30, 2015 and changes during the periods then ended is presented below:
 
   
December 31, 2015
    
June 30, 2015
  
         
Weight Average
    
Intrinsic
          
Weight Average
    
Intrinsic
  
   
Shares
    
Exercise Price
    
Value
    
Shares
    
Exercise Price
    
Value
  
Outstanding beginning of period
     2,270,000     $ 0.14             1,754,000     $ 0.17        
Granted
     1,030,000     $ 0.10             670,000     $ 0.10        
Expired/Cancelled
     -     $ 0.00             (154,000 )   $ (0.29 )      
Exercised
     -     $ 0.00             -     $ 0.00        
Outstanding end of period
     3,300,000     $ 0.13     $ 132,000       2,270,000     $ 0.14     $ 45,400  
Exercisable
     2,820,000     $ 0.13     $ 112,800       1,752,500     $ 0.16     $ 35,050  

 
AMERITYRE CORPORATION
Notes to the Unaudited Financial Statements
December 31, 2015
 
NOTE 6 - STOCK OPTIONS AND WARRANTS, Continued

The intrinsic value of outstanding and exercisable shares is based on the closing price of the Company’s common stock of $0.04 per share on December 31, 2015 ($0.02 per share on June 30, 2015), the last trading day of the quarter.

The following table summarizes the range of outstanding and exercisable options as of December 31, 2015:

     
Outstanding
    
Exercisable
  
 
Range of
Exercise Prices
    
Number Outstanding
at
December 31, 2015
    
Weighted
Average
Remaining
Contractual Life
    
 
Weighted
Average
Exercise Price
    
 
Number
Exercisable at
December 31, 2015
    
Weighted
Average Remaining
Contractual Life
  
$
0.08
      
150,000
      
5.92
    
$
0.08
      
150,000
      
5.92
  
$
0.10
      
1,700,000
      
3.96
    
$
0.10
      
1,220,000
      
3.96
  
$
0.17
      
650,000
      
3.92
    
$
0.17
      
650,000
      
3.92
  
$
0.17
      
400,000
      
4.92
    
$
0.17
      
400,000
      
4.92
  
$
0.17
      
400,000
      
5.92
    
$
0.17
      
400,000
      
5.92
  
         
3,300,000
                      
2,820,000
          

General Warrant Information

In September 2013, the Company obtained an extension on the remaining $100,000 secured convertible promissory note that was issued in the private placement that closed in September 2010.  This note was paid off as of June 30, 2015.   In exchange for the extension, the note holder received 500,000 common stock warrants and $6,500 in accrued interest and fees.  The common stock warrants expire three years from the date of issuance, are exercisable at $0.13 per share, and vest on the next date the value of Amerityre common stock reaches $0.25 per share.  As of December 31, 2015 the warrants have not vested.
 
NOTE 7 - LIQUIDITY

Over the past year, we have been working on various proposals to secure short-term loans as well as long-term bank financing and equity based investments. The Company currently does not have an existing credit facility. Over the past year, we have worked with our vendors to obtain extended credit terms and increase credit lines where needed. Additionally, we continue to focus on adherence to established collection policies and proactive communication with repeat customers, including adjusting credit limits to allow for increased sales volume where warranted.

We are intent on focusing on the sale and distribution of profitable product lines. Management continues to look for further financing facilities at affordable terms that will allow the Company to maintain sufficient raw material and finished goods inventory to capitalize on sales growth opportunities. No additional capital expenditures are anticipated over the next twelve months unless they support sales development and product improvement.  We continue to work to reduce our overall costs wherever possible.

To help address our cash resources which at times may be limited, we are in discussions with various third parties about potential opportunities to license our technology which we believe will bring in additional cash flows without diluting our common stock or requiring the addition of debt. We are in discussions with banks and other lenders regarding establishing a line of credit for short term cash needs, however at this time we have not succeeded in establishing such a line of credit.  Lastly, we have entered into a short term receivable factoring agreement with a third party to sell our receivable invoices.  This agreement enables us to sell individual customer invoices for faster cash flow to the Company as we deem needed.

As of December 31, 2015, the Company has approximately 7,064,000 shares authorized and available for issuance. Although we are reluctant to raise money through stock sales at what we believe are dilutive share prices, these authorized but unissued and unreserved shares of our common stock can be utilized if necessary to fund the expansion of our manufacturing operations or to obtain additional working capital.

The Company has also instituted initiatives to incentivize sales of slower moving inventory through promotional pricing. These programs will continue to be utilized in the upcoming quarters to monetize inventory and improve our cash flow.
 
 
AMERITYRE CORPORATION
Notes to the Unaudited Financial Statements
December 31, 2015

NOTE 7 - LIQUIDITY, Continued

In assessing our liquidity, management reviews and analyzes our current cash, accounts receivable, accounts payable, capital expenditure commitments and other obligations.  In connection with the preparation of our financial statements for the period ended December 31, 2015, we have analyzed our cash needs for the next twelve months. We have concluded that our available cash and accounts receivables are sufficient to meet our current minimum working capital, capital expenditure and other cash requirements for this period.

NOTE 8 - SUBSEQUENT EVENTS

On January 19, 2016, the Board granted all non-executive Board members 100,000 options, with the audit committee chair receiving an additional 50,000 options, for Board services rendered for the fiscal year ended June 30, 2016.  The options have a strike price of $0.10, vest at the end of the Board term in December 2016 and expire December 2019.  

On January 19, 2016, 50,000 options were granted to the Company’s Chief Financial Officer as part of renewal of her employment agreement.  The options have a strike price of $0.10, vest ratably January 21, 2016 to December 1, 2016 and expire December 1, 2019.  In addition to the option renewal $550 a month in health insurance reimbursement was included in the renewal.  All other terms remain the same.

In January 2016, 150,000 shares that had vested at December 31, 2015 for the CEO and CFO were issued.
 
 
 
 
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
This discussion and analysis contains statements of a forward-looking nature relating to future events or our future financial performance or financial condition.  Such statements are only predictions and the actual events or results may differ materially from the results discussed in or implied by the forward-looking statements. The historical results set forth in this discussion and analysis are not necessarily indicative of trends with respect to any actual or projected future financial performance.  This discussion and analysis should be read in conjunction with the financial statements and the related notes thereto included elsewhere in this report.
 
Overview

Amerityre engages in the research and development, manufacturing and sale of polyurethane tires.  We believe that we have developed unique polyurethane formulations that allow us to make products with superior performance characteristics, including abrasion resistance, energy efficiency and load-bearing capabilities, when compared to conventional rubber tires.  We also believe that our manufacturing processes are more energy efficient than the traditional rubber tire manufacturing processes, in part because our polyurethane compounds do not require the multiple processing steps, extreme heat, and high pressure that are necessary to cure rubber. Using our polyurethane technologies, we believe tires can be produced which last longer, are less susceptible to failure and are friendly to the environment.  
 
Over the past year changes in government regulations have made it difficult to source some raw materials in a cost effective manner. Amerityre has worked with its supplier base to successfully identify suitable replacements for these materials. This effort will continue during FY 2016. As always, Amerityre is committed to being in compliance with all government regulations while ensuring the quality of our products.
 
We are concentrating on three segments of the tire market: closed-cell polyurethane foam tires, polyurethane elastomer forklift tires and agricultural tires. Our focus continues to be applications and markets where our advantages in product technology give us an opportunity to obtain premium pricing. Our most recent activities in these areas are set forth below:
 
Closed-Cell Polyurethane Tires – The sale of polyurethane foam tires to original equipment manufacturers, distributors and dealers accounts for the majority of our revenue. We have the ability to produce a broad range of products for the light duty tire market. Marketing and research and development efforts continue to build customer relationships with original equipment manufacturers and further develop distribution networks to expand business and product sales.
 
Polyurethane Elastomer Forklift Tires – During 2014 the forklift product line was reintroduced into the marketplace.  Sales have been below expectations and during FY 2015 a project was launched to source suitable formulation components to replace those that are unavailable, as mentioned above. This new formulation is expected to be completed and tested during the second half of FY 2016, at which time this product line will be reintroduced to the market. 

Agricultural Tires – Sales of agricultural tires has been negatively impacted by the dramatic downturn in farm commodity prices. Our experience is consistent with the reports provided by large agricultural equipment suppliers, several who have announced expectations for another challenging year for farmer income and farm- related spending. Despite growing market acceptance of the pivot tire, financial considerations have forced potential pivot tire customers to delay purchases.  We continue to focus on developing improvements in pivot tire design and in our tire manufacturing capabilities.  The pursuit of additional distribution relationships to increase our market penetration for the pivot tire is a key component to our strategy.  

Due to the Company’s limited resources, tire projects which are contingent on additional significant development, such as composite and automotive tires, have been put on hold and will be revisited at a later date.

As described above, we are focused on diverse market segments which are unrelated in terms of customer base, product, distribution, market demands and competition. Our sales team is comprised of two manufacturer representatives whose experience is complementary to our product portfolio plus our in-house sales department.  The Company’s emphasis on proper product pricing and new marketing campaigns has driven more profitable sales for Amerityre.  These initiatives started to be evident in our third quarter 2015 results. During the fourth quarter 2015 Amerityre achieved net income for the quarter for the first time in Company history, supporting our goal to establish “Profitability as a Mindset”.  These changes to our operating structure helped to minimize the losses experienced during the second quarter of fiscal year 2016.  We continue to have a solid backlog for orders to be delivered over the next 12 months.  However, going forward the challenging economic environment may continue to negatively impact our results in all market segments.
 

Factors Affecting Results of Operations
 
Our operating expenses consisted primarily of the following:
 
 
·  
Cost of sales, which consists primarily of raw materials, components and production of our products, including applied labor costs and benefits expenses, maintenance, facilities and other operating costs associated with the production of our products;

 
·  
Selling, general and administrative expenses, which consist primarily of salaries, commissions and related benefits paid to our employees and related selling and administrative costs including professional fees;

 
·  
Research and development expenses, which consist primarily of contractor and direct labor conducting research and development, equipment and materials used in new product development and product improvement using our technologies;

 
·  
Consulting expenses, which consist primarily of amounts paid to third-parties for outside services;

 
·  
Depreciation and amortization expenses which result from the depreciation of our property and equipment, including amortization of our intangible assets; and

 
·  
Stock based compensation expense related to stock and stock option awards issued to employees and consultants for services performed for the Company.

 Critical Accounting Policies

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with United States generally accepted accounting principles.  The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses.  On an ongoing basis, we evaluate our estimates, including those related to uncollectible receivables, inventory valuation, deferred compensation and contingencies.  We base our estimates on historical performance and on various other assumptions that we believe to be reasonable under the circumstances.  These estimates allow us to make judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.

We believe the following accounting policies are our critical accounting policies because they are important to the portrayal of our financial condition and results of operations and they require critical management judgments and estimates about matters that may be uncertain.  If actual results or events differ materially from those contemplated by us in making these estimates, our reported financial condition and results of operations for future periods could be materially affected.

Revenue Recognition

Revenue for products is recognized when the sales amount is determined, shipment of goods to the customer has occurred and collection is reasonably assured. Generally, we ship all of our products FOB origination.
 
Valuation of Intangible Assets and Goodwill

Patent and trademark costs have been capitalized at December 31, 2015, totaling $479,633 with accumulated amortization of $290,588 for a net book value of $189,045. Patent and trademark costs capitalized at June 30, 2015, $479,633 with accumulated amortization of $276,923 for a net book value of $202,710.

The patents which have been granted are being amortized over a period of 20 years. Patents which are pending or are being developed are not amortized. Amortization begins once the patents have been issued. Annually, pending or expired patents are inventoried and analyzed.  As of December 31, 2015 and 2014, respectively, there was no recognition of a loss on abandonment, expiration or retirement of patents and trademarks.
 

Amortization expense for the six months ended December 31, 2015 and 2014 was $13,666 and $16,026, respectively.  The Company evaluates the recoverability of intangibles and reviews the amortization period on a continual basis utilizing the guidance of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 350, Intangibles – Goodwill and Other.  We consider the following indicators, among others, when determining whether or not our patents are impaired:

 
·  
any changes in the market relating to the patents that would decrease the life of the asset;

 
·  
any adverse change in the extent or manner in which the patents are being used;

 
·  
any significant adverse change in legal factors relating to the use of the patents;

 
·  
current period operating or cash flow loss combined with our history of operating or cash flow losses;

 
·  
future cash flow values based on the expectation of commercialization through licensing; and
 
 
·  
current expectations that, more likely than not, the patents will be sold or otherwise disposed of significantly before the end of its previously estimated useful life.

Inventory
 
Inventory is stated at the lower of cost (computed on a first-in, first-out basis) or market. The cost of finished goods includes the cost of raw material, direct and indirect labor, and other indirect manufacturing costs. The inventory consists of chemicals, finished goods produced in the Company’s plant and products purchased for resale.

Financial and Derivative Instruments

The Company periodically enters into financial instruments. Upon entry, each instrument is reviewed for debt or equity treatment.  In the event that the debt or equity treatment is not readily apparent, FASB ASC 480-10-S99 is consulted for temporary treatment.  Once an event takes place that removes the temporary element the Company appropriately reclassifies the instrument to debt or equity. 

The Company periodically assesses its financial and equity instruments to determine if they require derivative accounting. Instruments which may potentially require derivative accounting are conversion features of debt, equity, and common stock equivalents in excess of available authorized common shares, and contracts with variable share settlements.  In the event of derivative treatment, we mark the instrument to market.

Stock-Based Compensation

We account for stock-based compensation under the provisions of Accounting Standards Codification 718, Compensation – Stock Compensation (ASC 718).  Our financial statements as of and for the quarters ended December 31, 2015 and 2014 reflect the impact of ASC 718.  Stock-based compensation expense related to director, employee or consultant options recognized under ASC 718 for the six months ended December 31, 2015 and 2014 was $41,795 and $13,571, respectively.
 
ASC 718 requires companies to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model.  The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in our Statement of Operations.  Stock-based compensation expense recognized in our Statements of Operations for the quarters ended December 31, 2015 and 2014 assumes all awards will vest; therefore no reduction has been made for estimated forfeitures.  We have awarded some options with a performance requirement and no amounts will be recorded until the requirement is met.
 
 
Results of Operations
 
Our management reviews and analyzes several key performance indicators in order to manage our business and assess the quality and potential variability of our sales and cash flows.  These key performance indicators include:
 
 
·  
Sales consisting of product sales;
 
 
·  
Sales, net of returns and trade discounts, which is an indicator of our overall business growth and the success of our sales and marketing efforts;
 
 
·  
Gross profit, which is an indicator of both competitive pricing pressures and the cost of goods sold of our products and the mix of product and license fees, if any;
 
 
·  
Growth in our customer base, which is an indicator of the success of our sales efforts; and
 
 
·  
Distribution of sales across our products offered.
 
The following summary table presents a comparison of our results of operations for the three and six months ended December 31, 2015 and 2014 with respect to certain key financial measures.  The comparisons illustrated in the table are discussed in greater detail below. 
 
   
For the Three Months Ended
December 31,
        
For the Six Months Ended
December 31
        
   
(in 000’s)
    
Change
  
(in 000’s)
    
Change
  
   
2015
    
2014
    
2015 vs. 2014
  
2015
    
2014
    
2015 vs. 2014
  
Net revenues
  
$
915
    
$
1,349
      
(32.2
%)
  
$
1,929
    
$
2,381
      
(19.0
%)
Cost of revenues
    
(697
 )    
(1,035
 )    
(32.7
%)
    
(1,464
 )    
(1,837
)
    
(20.3
%)
Gross profit
    
218
      
314
      
(30.6
%)
    
465
      
544
      
(14.5
%)
Research  and development expenses
    
(56
 )    
(58
 )    
(3.4
%)
    
(110
 )    
(97
)
    
13.4
%
Sales and marketing expense
    
(69
 )    
(167
 )    
(58.7
%)
    
(166
 )    
(286
 )    
(42.0
%)
General and administrative expense
    
(270
 )    
(217
 )    
24.4
%
    
(495
 )    
(448
 )    
10.5
%
Other income (expense)
    
-
      
-
        
-
    
(1
 )    
-
      
100.0
%
Net loss
    
(177
)
    
(128
)
    
38.3
%
    
(307
)
    
(287
)
    
7.0
%
Preferred stock dividend
    
(25
)
    
(25
)
    
0.0
%
    
(50
)
    
(50
)
    
0.0
%
Net loss attributable to common shareholders
  
$
(202
)
  
$
(153
)
    
32.0
%
  
$
(357
)
  
$
(337
)
    
6.0
%
 
As disclosed in our June 30, 2015 Annual Report on Form 10-K, although our sales no longer show strong seasonality trends, our fiscal first quarter has traditionally been our weakest quarter and we again saw this trend in FY 2016.  We expected agricultural tires to occur during the second quarter of 2016, but this did not materialize due to poor economic conditions that affected farmer income and spending.  In addition, during the recent quarter we experienced lower than expected sales in our other market segments.  This is consistent with reports from other equipment and parts manufacturers, who noted a general softness in manufacturing activity and sales last quarter.  If this forecast holds, it may adversely impact our sales as the slowdown in agricultural equipment sales extends to equipment expenditures across the board.

Three Months Ended December 31, 2015 Compared to December 31, 2014
 
Net Sales.  Net sales of $914,888 for the quarter ended December 31, 2015, represents a 32.2% decrease over net sales of $1,349,336 for the same period in 2014.  These results were not in line with our expectations as we anticipated that we would have stronger pivot tire sales for the period. Our sales were driven primarily by closed cell foam tire sales in the mobility segment, as a major customer took delivery of product for their seasonal product launch. We have also seen good response to our new marketing and pricing plans for our polyurethane foam tires, which has helped to maintain our sales backlog level. Our plan for the fiscal 2016 third quarter includes higher pivot tire sales, which we expect as farmers purchase farm equipment and replacement parts in preparation for the next growing season. We are optimistic that these sales will occur since pivot sales in the last quarter were deferred by farmers.  However, lower crop prices and reduced yields due to unusual weather in certain areas of the country may continue to negatively impact farm income and the timing and amount of pivot tire sales, as it has on other agricultural equipment spending.
 
 
Cost of Revenues.  Cost of revenues for the quarter ended December 31, 2015 was $696,671 or 76.1% of sales compared to $1,035,209 or 76.7% of sales for the same period in 2014. Cost of revenues were lower due to decreases in raw materials expenditures and overhead costs (specifically lower damaged returns) partially offset by higher manufacturing supply costs when compared to the prior period.  Starting July 1, 2015 the Company modified it customer freight policy, providing savings of approximately $23,000 for this period. The Company continues to maintain sufficient production capacity to meet anticipated customer demand without incurring a proportionate increase in overall production costs. 

Gross Profit.  Gross profit for the quarter ended December 31, 2015 was $218,217 compared to $314,127 for the same period in 2014. Gross profit for the quarter ended December 31, 2015 decreased by $95,910 or 30.6% over the same period in 2014 due to the decrease in revenue offset by the savings in cost of revenue outlined in the discussion above.  The December 31, 2015 gross profit reflects a 23.9% gross margin for product sales compared to a gross margin on product sales of 23.3% in 2014.
 
Research & Development Expenses (R&D).  Research and development expenses for the quarter ended December 31, 2015 were $55,962 compared to $57,646 for the same period in 2014. Research and development expenses decreased $1,684 between periods, resulting in a relatively flat period over period result, as we continue to focus on product formulation research and product testing, and maintain a part-time chemist on site.  The Company plans to continue this level of expenditure as R&D is a key component of the company business improvement initiatives.
 
Sales & Marketing Expenses. Sales and marketing expenses for the quarter ended December 31, 2015 were $68, 595 compared to $167,346 for the same period in 2014. Sales and marketing expenses decreased $98,751 or 58.7% between periods primarily due to lower travel costs, fewer trade show expenses for the quarter, a reduction in outside sales representatives (from 3 to 2), lower print advertising expense and the effect of the modifications to the 2015 sales commission program. All other expenses were generally consistent between periods.  The reduction in outside sales representatives did not have a material impact on our revenues.

General & Administrative Expenses.  General and administrative expenses for the quarter ended December 31, 2015 were $269,800 compared to $217,759 for the same period in 2014. General and administrative expenses increased $52,041 between periods primarily due to increases in stock based compensation and warranty expense, and salaries offset by savings in consulting expense and director travel costs.  All other expenses were generally consistent between periods.

Other Income/(Expense).  Other expense for the quarter ended December 31, 2015 was $899 compared to other income $159 for the same period in 2014. In July 2015, the Company leased equipment resulting in $935 in interest expense for the quarter.  The Company had no interest expense in the same period in 2014.
 
Net Loss.  Net loss for the quarter ended December 31, 2015 of $177,039 represents a 38.3% increase in net loss compared to the quarter ended December 31, 2014 loss of $128,465.  

Six Months Ended December 31, 2015 Compared to December 31, 2014

Net Sales.  Net sales of $1,928,821 for the six months ended December 31, 2015, represents a 19.0% decrease over net sales of $2,381,060 for the same period in 2014. These results were not in line with our expectations as we anticipated that we would have stronger pivot tire sales for the collective six months. Our sales were driven primarily by closed cell foam tire sales in the mobility segment, as a major customer began taking delivery of product for their seasonal product launch. We have also seen good response to our new marketing and pricing plans for our polyurethane foam tires, which has helped to maintain our sales backlog level. Our plan for the fiscal 2016 third quarter includes higher pivot tire sales, which we expect to increase as farmers increase purchases of farm equipment in preparation for the next growing season. We are optimistic that these sales will occur although lower crop prices and reduced yields due to unusual weather in certain areas of the country may negatively impact farm income and the timing and level of pivot tire sales, as it has with spending on other agricultural equipment.
 
Cost of Revenues.  Cost of revenues for the six months ended December 31, 2015 was $1,463,447 or 75.9% of sales compared to $1,836,865 or 77.1% of sales for the same period in 2014. Cost of revenues were lower due to decreases in raw materials expenditures, direct labor and overhead costs consisting of lower damaged returns partially offset by higher manufacturing repairs and maintenance and manufacturing supplies when compared to the prior period.  Starting July 1, 2015 the Company modified it customer freight policy, providing savings of approximately $53,000 for six months ended December 31, 2015. The Company continues to maintain sufficient production capacity to meet anticipated customer demand without incurring a proportionate increase in overall production costs. 
 

Gross Profit.  Gross profit for the six months ended December 31, 2015 was $465,374 compared to $544,195 for the same period in 2014. Gross profit for the quarter ended December 31, 2015 decreased by $78,821 or 14.5% over the same period in 2014 due to the decrease in revenue offset by the savings in cost of revenue outlined in the discussion above.  The December 31, 2015 gross profit reflects a 24.1% gross margin for product sales compared to a gross margin on product sales of 22.9% in 2014.
 
Research & Development Expenses (R&D).  Research and development expenses for the six months ended December 31, 2015 were $109,567 compared to $97,490 for the same period in 2014. Research and development expenses increased $12,077 between periods due to a full 6 months of having a part-time chemist on site, as we continue to focus on product formulation research and product testing.  The Company plans to continue this level of expenditure as R&D is a key component of the company business improvement initiatives as resources allow.
 
Sales & Marketing Expenses. Sales and marketing expenses for the six months ended December 31, 2015 were $166,259 compared to $286,205 for the same period in 2014. Sales and marketing expenses decreased $119,946 or 42.0% between periods primarily due to lower travel costs, fewer trade show expenses, a reduction in outside sales representatives (from 3 to 2), lower print advertising expense and the effect of the 2015 sales commission program. All other expenses were generally consistent between periods.  The reduction in outside sales representatives did not have a material impact on our revenues.

General & Administrative Expenses.  General and administrative expenses for the six months ended December 31, 2015 were $494,640 compared to $448,295 for the same period in 2014. General and administrative expenses increased $46,345 between periods primarily due to increases in stock based compensation, legal fees, warranty expense and salaries offset by savings in consulting and professional expenses, director travel costs and investor relations expense.  All other expenses were generally consistent between periods.

Other Income/(Expense).  Other expense for the six months ended December 31, 2015 was $1,425 compared to other income $366 for the same period in 2014. In July 2015, the Company leased equipment resulting in $1,534 in interest expense for the six months. The Company had no interest expense in the same period in 2014.
 
Net Loss.  Net loss for the six months ended December 31, 2015 of $306,517 represents a 7.0% increase in net loss for the six months ended December 31, 2014 of $287,429.  

Liquidity and Capital Resources
 
Our principal sources of liquidity are of cash and payments received from our customers.  We do not have any significant credit arrangements.  Historically, our expenses have exceeded our sales, resulting in operating losses.  From time to time, we have obtained additional liquidity to fund our operations through the sale of shares of our common stock and the placement of short-term debt instruments.   Management continues to evaluate financing options but to date has chosen to delay financing at terms that will subject the Company to high costs of debt or will raise money through stock sales at what we believe are highly dilutive share prices.

We have historically not succeeded in establishing favorable short term financing but we continue to maintain a short term receivable factoring agreement with a third party to sell our receivable invoices.  This agreement enables us to sell individual customer invoices for faster cash flow to the Company as we deem needed.  As of December 31, 2015 we have not needed to activate this financing option due to increased focus on adherence to established collection policies and proactive communication with repeat customers, adjusting credit limits to allow for increased sales volume.
 
Cash Flows
 
The following table sets forth our cash flows for the quarters ended December 31, 2015 and 2014.
 
   
Six Months ended Dec. 31,
  
   
(in 000’s)
  
   
2015
    
2014
  
Net cash used by operating activities
  
$
(246
)
  
$
(272
)
Net cash used in investing activities
    
-
      
(32
)
Net cash used by financing activities
    
(53
)
    
(52
) 
Net decrease in cash during the period
  
$
(299
)
  
$
(356
)
 
 
Net Cash Used by Operating Activities. Our primary sources of operating cash during the quarter ended December 31, 2015 came from collections from customers, however, our period end receivables balance decreased as we waited for several large customers to remit payment in early January 2016 upon returning from the December 2015 holidays. Our primary use of operating cash was an increase in prepaid and other current assets, specifically related to renewal of insurance policies.  Net cash used by operating activities was $246,244 for the six months ended December 31, 2015 compared to net cash used by operating activities of $272,253 for the same period in 2014. 

Non-cash items include depreciation and amortization and stock based compensation.  Our net loss was $306,517 for the six months ended December 31, 2015 compared to a net loss of $287,429 for the same period in 2014.  The net loss for fiscal 2015 included non-cash expenses for depreciation and amortization of $81,028 and stock-based compensation (both stock issued and options) of $41,795.  As of December 31, 2014, depreciation and amortization was $90,627 and stock-based compensation (both stock issued and options) totaled $13,571.
  
Net Cash Used by Investing Activities.  Net cash used by investing activities was $0 for the six months ended December 31, 2015 and $31,721 for the same period in 2014.  Although we did not purchase equipment as of December 31, 2015 we did lease equipment for research and development purposes.  

Net Cash Used by Financing Activities.  Net cash used by financing activities was $53,185 for the six months ended December 31, 2015 and $51,648 for the same period in 2014. The primary use of cash for the quarter ended December 31, 2015 was payment toward the capital lease of $2,018, payment of notes payable of $1,167 and payment of preferred share dividend of $50,000.
 
Contractual Obligations and Commitments
 
The following table summarizes our contractual cash obligations and other commercial commitments at December 31, 2015.
 
   
Payments due by period
  
   
Total
    
Less than 1 year
    
1 to 3 years
    
3 to 5 years
    
After 5 years
  
Facility lease (1)
  
$
618,600
    
$
136,200
    
$
275,100
    
$
207,300
    
$
-
  
Capital lease for equipment
    
22,468
      
8,697
      
13,771
      
-
      
-
  
Preferred share dividend
    
450,000
      
100,000
      
200,000
      
150,000
      
-
  
Total contractual cash obligations
  
$
1,091,068
    
$
244,897
    
$
488,871
    
$
357,300
    
$
-
  

(1)  
In May 2015, we negotiated a five (5) year extension of the lease on our executive office and manufacturing facility located at 1501 Industrial Road, Boulder City, Nevada.  The property consists of a 49,200 square foot building.  We currently occupy all 49,200, inclusive of approximately 5,500 square feet of office space, situated on approximately 4.15 acres.  All other terms and conditions of the building lease remain in effect.
 
Cash Position, Outstanding Indebtedness and Future Capital Requirements
 
At February 8, 2016, our total cash balance was $124,717 none of which is restricted; accounts receivables was $287,565; and inventory, net of reserves for slow moving or obsolete inventory, and other current assets was $545,461. Our total indebtedness was $273,109 and includes $65,080 in accounts payable, $124,856 in accrued expenses, $12,441 in current portion of long-term debt, $16,892 in capital lease liability and $53,840 in long-term debt.
 
Over the past year, we have been working on various proposals to secure short-term loans as well as long-term bank financing and equity based investments. The Company currently does not have an existing credit facility. Over the past year, we have worked with our vendors to obtain extended credit terms and increase credit lines where needed. Additionally, we continue to focus on adherence to established collection policies and proactive communication with repeat customers, including adjusting credit limits to allow for increased sales volume where warranted.
 
 
We are intent on focusing on the sale and distribution of profitable product lines. Although, management continues to look for further financing facilities at affordable terms that will allow the Company to maintain sufficient raw material and finished goods inventory to capitalize on sales growth opportunities, no additional capital expenditures are anticipated over the next twelve months unless they support sales development and product improvement.  We continue to work to reduce our overall costs wherever possible.
 
To help address our cash resources which at times may be limited, we are in discussions with various third parties about potential opportunities to license our technology which we believe will bring in additional cash flows without diluting our common stock or requiring the addition of debt. We are in discussions with banks and other lenders regarding establishing a line of credit for short term cash needs, however at this time we have not succeeded in establishing such a line of credit.  Lastly, we have entered into a short term receivable factoring agreement with a third party to sell our receivable invoices.  This agreement enables us to sell individual customer invoices for faster cash flow to the Company as we deem needed.

At the Annual Stockholder’s Meeting held on December 4, 2014, management presented a plan focusing on “Profitability as a Mindset”.  To that end, management continues to sharpen our sales model and our marketing approach. The result of the Company’s emphasis on proper product pricing and new marketing campaigns has driven more profitable sales for Amerityre, which started to be evident in our third and fourth quarter 2015 results.  Fourth quarter 2015 resulted in net income for the quarter for the first time in Company history.  Although we were not able to achieve similar net income results in the current quarter, we believe these changes are supporting our goal to establish “Profitability as a Mindset”, and management and the Company’s Board of Directors are committed to continuing these efforts. 

In assessing our liquidity, management reviews and analyzes our current cash, accounts receivable, accounts payable, capital expenditure commitments and other obligations.  In connection with the preparation of our financial statements for the period ended December 31, 2015, we have analyzed our cash needs for the next twelve months. We have concluded that our available cash and accounts receivables are sufficient to meet our current minimum working capital, capital expenditure and other cash requirements for this period.  However, to expand manufacturing and sales operations beyond the current level, additional capital may be required.

The Company has instituted initiatives to incentivize sales of slower moving inventory through promotional pricing. These programs will continue to be utilized in the upcoming quarters to monetize inventory and improve our cash flow.

As of February 8, 2016, the Company has approximately 7,064,000 shares authorized and available for issuance. Although we are reluctant to raise money through stock sales at what we believe are dilutive share prices, these authorized but unissued and unreserved shares of our common stock can be utilized if necessary to fund the expansion of our manufacturing operations or to obtain additional working capital.
 
Off-Balance Sheet Arrangements
 
We do not currently have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. In addition, we do not engage in trading activities involving non-exchange traded contracts.
 
 
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are exposed to changes in prevailing market interest rates affecting the return on our investments but do not consider this interest rate market risk exposure to be material to our financial condition or results of operations.  We invest primarily in United States Treasury instruments with short-term (less than one year) maturities.  The carrying amount of these investments approximates fair value due to the short-term maturities.  Under our current policies, we do not use derivative financial instruments, derivative commodity instruments or other financial instruments to manage our exposure to changes in interest rates or commodity prices.
 
ITEM 4. CONTROLS AND PROCEDURES

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

As required by SEC Rule 13a-15(b), an evaluation was performed under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) as of the end of the period covered by this report. Based upon that evaluation, our Chief Executive Officer and our Chief Financial Officer, concluded that the design and operation of these disclosure controls and procedures were effective at the reasonable assurance level. There has been no change in our internal controls over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.
 
 
 
 PART II - OTHER INFORMATION
 
ITEM 1.  LEGAL PROCEEDINGS

None.
 
ITEM 1A. RISK FACTORS

For information regarding risk factors, see “Part I. Item 1A. Risk Factors,” in our Annual Report on Form 10-K for the year ended June 30, 2015.

ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.
 
ITEM 3.  DEFAULTS UPON SENIOR SECURITIES

None.
 
ITEM 4.  MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5.  OTHER INFORMATION

None.
 
ITEM 6.  EXHIBITS
 
31.1
   
31.2
   
32.1
   
32.2
   
101 INS
XBRL Instance Document
   
101 SCH
XBRL Taxonomy Extension Schema Document
   
101 CAL
XBRL Taxonomy Extension Calculation Linkbase Document
   
101 DEF
XBRL Taxonomy Extension Definition Linkbase Document
   
101 LAB
XBRL Taxonomy Extension Label Linkbase Document
   
101 PRE
XBRL Taxonomy Extension Presentation Linkbase Document
 
 
SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated:  February 10, 2016
 
AMERITYRE CORPORATION
      
By:
      
/s/ Michael F. Sullivan
  
/s/ Lynda R. Keeton-Cardno
  
Michael F. Sullivan
Chief Executive Officer
(Principal Executive Officer)
  
Lynda R. Keeton-Cardno
Chief Financial Officer
(Principal Financial and Accounting Officer)
  
 
 
 
 
 
 
22
 
 
 
 EX-31.1 2 ex31-1.htm EX-31.1 ex31-1.htm
 
EXHIBIT 31.1
 
CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICER PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Michael F. Sullivan, certify that:

1.           I have reviewed this quarterly report on Form 10-Q of Amerityre Corporation for the three and six months ended December 31, 2015;

2.           Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.           Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.           I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and I have:

(a)           designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)           designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)           presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on our evaluation; and

(d)           disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

5.           I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)           all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)           any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: February 10, 2016
 
/s/ Michael F. Sullivan              
Michael F. Sullivan
Chief Executive Officer
(Principal Executive Officer)
 

 
 
 
 
 
 EX-31.2 3 ex31-2.htm EX-31.2 ex31-2.htm
EXHIBIT 31.2
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of Amerityre Corporation (the "Company") on Form 10-Q for the three and six months ended December 31, 2015, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Michael F. Sullivan, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley  Act of 2002, that, to the best of my knowledge and belief:

 
(1)
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 
(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.


/s/ Michael F. Sullivan                  
Michael F. Sullivan
Chief Executive Officer
(Principal Executive Officer)

February 10, 2016
 

 
 
 
 
EX-32.1 4 ex32-1.htm EX-32.1 ex32-1.htm
EXHIBIT 32.1
 
CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICER PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Lynda R. Keeton-Cardno, certify that:

1.           I have reviewed this quarterly report on Form 10-Q of Amerityre Corporation for the three and six months ended December 31, 2015;

2.           Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.           Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.           I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and I have:

(a)           designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)           designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)           presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on our evaluation; and

(d)           disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

5.           I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)           all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)           any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: February 10, 2016
 
/s/ Lynda R. Keeton-Cardno                  
Lynda R. Keeton-Cardno
Chief Financial Officer
(Principal Financial Officer)

 
 
 
 
 
EX-32.2 5 ex32-2.htm EX-32.2 ex32-2.htm
EXHIBIT 32.2
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of Amerityre Corporation (the "Company") on Form 10-Q for the three and six months ended December 31, 2015, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Lynda R. Keeton-Cardno, Chief  Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley  Act of 2002, that, to the best of my knowledge and belief:

 
(1)
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 
(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.


/s/ Lynda R. Keeton-Cardno                  
Lynda R. Keeton-Cardno
Chief Financial Officer
(Principal Financial Officer)

February 10, 2016

 EX-101.INS 6 amty-20151231.xml EX-101.INS 0000945828 2015-12-31 0000945828 2015-06-30 0000945828 2015-10-01 2015-12-31 0000945828 2014-10-01 2014-12-31 0000945828 2015-07-01 2015-12-31 0000945828 2014-07-01 2014-12-31 0000945828 2014-06-30 0000945828 2014-12-31 0000945828 2016-02-08 0000945828 us-gaap:AffiliatedEntityMember 2015-07-01 2015-12-31 0000945828 2015-07-31 0000945828 amty:EachEmployeeMember 2015-07-22 2015-07-22 0000945828 2015-07-22 0000945828 2015-07-22 2015-07-22 0000945828 2015-07-20 2015-07-20 0000945828 2015-07-20 0000945828 us-gaap:ChiefExecutiveOfficerMember 2015-07-20 2015-07-20 0000945828 us-gaap:ChiefFinancialOfficerMember 2015-07-20 2015-07-20 0000945828 amty:CEOAndCFOMember 2015-07-01 2015-12-31 0000945828 amty:CEOAndCFOMember 2015-12-31 0000945828 amty:Directors2011StockOptionAndAwardPlanMember 2011-07-06 0000945828 amty:Directors2011StockOptionAndAwardPlanMember 2011-07-06 2011-07-06 0000945828 amty:OmnibusStockOptionAndAward2015PlanMember 2015-08-10 0000945828 us-gaap:ChiefExecutiveOfficerMember 2014-12-01 2014-12-01 0000945828 us-gaap:ChiefExecutiveOfficerMember 2014-12-01 0000945828 us-gaap:ChiefExecutiveOfficerMember 2015-07-01 2015-12-31 0000945828 us-gaap:ChiefFinancialOfficerMember 2015-01-21 2015-01-21 0000945828 us-gaap:ChiefFinancialOfficerMember 2015-01-21 0000945828 us-gaap:MinimumMember us-gaap:ChiefFinancialOfficerMember 2015-01-21 2015-01-21 0000945828 us-gaap:MaximumMember us-gaap:ChiefFinancialOfficerMember 2015-01-21 2015-01-21 0000945828 us-gaap:ChiefFinancialOfficerMember 2015-07-01 2015-12-31 0000945828 amty:BoardMemberMember 2015-10-01 2015-10-31 0000945828 amty:AuditCommitteeChairMember 2015-10-01 2015-10-31 0000945828 amty:BoardMemberMember 2015-10-31 0000945828 amty:BoardMemberMember 2015-07-01 2015-12-31 0000945828 us-gaap:ChiefExecutiveOfficerMember 2015-12-01 2015-12-01 0000945828 us-gaap:ChiefExecutiveOfficerMember 2015-12-01 0000945828 us-gaap:ConvertibleDebtMember 2013-09-30 0000945828 us-gaap:ConvertibleDebtMember 2013-09-01 2013-09-30 0000945828 us-gaap:MinimumMember 2015-07-01 2015-12-31 0000945828 us-gaap:MaximumMember 2015-07-01 2015-12-31 0000945828 2014-07-01 2015-06-30 0000945828 amty:OptionsAt0.08Member 2015-12-31 0000945828 amty:OptionsAt0.08Member 2015-07-01 2015-12-31 0000945828 amty:OptionsAt0.10Member 2015-12-31 0000945828 amty:OptionsAt0.10Member 2015-07-01 2015-12-31 0000945828 amty:OptionsAt017Member 2015-12-31 0000945828 amty:OptionsAt017Member 2015-07-01 2015-12-31 0000945828 amty:OptionsAt17Cents2Member 2015-12-31 0000945828 amty:OptionsAt17Cents2Member 2015-07-01 2015-12-31 0000945828 amty:OptionsAt17Cents3Member 2015-12-31 0000945828 amty:OptionsAt17Cents3Member 2015-07-01 2015-12-31 0000945828 amty:BoardMemberMember us-gaap:SubsequentEventMember 2016-01-19 2016-01-19 0000945828 us-gaap:BoardOfDirectorsChairmanMember us-gaap:SubsequentEventMember 2016-01-19 2016-01-19 0000945828 amty:BoardMemberMember us-gaap:SubsequentEventMember 2016-01-19 0000945828 us-gaap:ChiefFinancialOfficerMember us-gaap:SubsequentEventMember 2016-01-19 2016-01-19 0000945828 us-gaap:ChiefFinancialOfficerMember us-gaap:SubsequentEventMember 2016-01-19 0000945828 amty:MonthlyHealthInsuranceReimbursementMember us-gaap:ChiefFinancialOfficerMember us-gaap:SubsequentEventMember 2016-01-19 0000945828 amty:CEOAndCFOMember us-gaap:SubsequentEventMember 2016-01-01 2016-01-31 iso4217:USD iso4217:USD xbrli:shares xbrli:shares xbrli:pure 156288 455717 312891 314054 0 6312 646012 661129 96128 27860 1211319 1465072 153543 153543 572894 572894 2964900 2937922 74921 74921 305924 305924 3803107 3735744 269075 309460 189045 202710 195778 186560 11000 11000 395823 400270 1876217 2174802 438664 438680 12441 13608 5642 0 456747 452288 53840 53840 11677 0 65517 53840 522264 506128 2000 2000 41800 41570 62552922 62515856 4500 0 -61247269 -60890752 1353953 1668674 1876217 2174802 0.001 0.001 5000000 5000000 2000000 2000000 2000000 2000000 0.001 0.001 75000000 75000000 41800287 41441620 41800287 41441620 914888 1349336 1928821 2381060 696671 1035209 1463447 1836865 218217 314127 465374 544195 55962 57646 109567 97490 68595 167346 166259 286205 269800 217759 494640 448295 394357 442751 770466 831990 -176140 -128624 -305092 -287795 935 0 1534 0 36 159 109 366 -899 159 -1425 366 -177039 -128465 -306517 -287429 25000 25000 50000 50000 -202039 -153465 -356517 -337429 0.00 0.00 -0.01 -0.01 41731809 41441620 41681483 41441620 81028 90627 -289 -8066 0 5147 41795 13571 -7764 110633 -5899 -53115 68268 29015 -7656 430 -246244 -272253 0 31721 0 -31721 2018 0 1167 1460 0 188 50000 50000 -53185 -51648 -299429 -355622 728585 372963 1534 0 0 0 19337 0 6312 0 7641 0 Amerityre Corp 10-Q --06-30 41950287 false 0000945828 Yes No Smaller Reporting Company No 2016 Q2 2015-12-31 <div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">The accompanying unaudited condensed financial statements have been prepared by us pursuant to the rules and regulations of the Securities and Exchange Commission.&nbsp;&nbsp;Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted in accordance with such rules and regulations.&nbsp;&nbsp;The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements.&nbsp;&nbsp;We believe the disclosures and information presented are adequate to make the information not misleading.&nbsp;&nbsp;These interim condensed financial statements should be read in conjunction with our most recent audited financial statements and notes thereto included in our June 30, 2015 Annual Report on Form 10-K.&nbsp;&nbsp;Operating results for the six months ended December 31, 2015 are not necessarily indicative of the results that may be expected for the current fiscal year ending June 30, 2016.</font> </div><br/> <div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Significant accounting policies disclosed therein have not changed since our audited financial statements and notes thereto included in our June 30, 2015 Annual Report on Form 10-K, except as noted below.</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline">Reclassifications</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Certain reclassifications, which have no effect on net loss, have been made in the prior period financial statements, specifically the recognition of the preferred share dividend as a non-cash transaction at December 31, 2014.</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline">Trade Receivables</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">We generally charge-off trade receivables that are more than 120 days outstanding as bad-debt expense, unless management believes the amount to be collectable. The charge-off amounts are included in general and administrative expenses.&nbsp;As of December 31, 2015 and 2014, the reserve for uncollectible accounts was $-0- and $7,296, respectively.</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline">Stock Based-Compensation Expense</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">We account for stock-based compensation under the provisions of Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) 718, <font style="FONT-STYLE: italic; DISPLAY: inline">Compensation &#x2013; Stock Compensation</font> (ASC 718).&nbsp;&nbsp;Our financial statements as of and for the quarters ended December 31, 2015 and 2014 reflect the impact of ASC 718.&nbsp;&nbsp;Stock-based compensation expense related to director, employee or consultant options recognized under ASC 718 for the six months ended December 31, 2015 and 2014 was $41,795 and $13,571, respectively.</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">ASC 718 requires companies to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model.&nbsp;&nbsp;The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in our Statement of Operations.&nbsp;&nbsp;Stock-based compensation expense recognized in our Statements of Operations for the six months ended December 31, 2015 and 2014 assumes all awards will vest; therefore no reduction has been made for estimated forfeitures.&nbsp;&nbsp;We have awarded some options with a performance requirement and no amounts will be recorded until the requirement is met.</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline">Basic and Fully Diluted Net Loss Per Share</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Basic and Fully Diluted net loss per share is computed using the weighted-average number of common shares outstanding during the period.</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Our outstanding stock options and warrants and shares issuable upon conversion of outstanding convertible notes have been excluded from the basic and fully diluted net loss per share calculation.&nbsp;&nbsp;We excluded 3,700,000 and 2,834,000 common stock equivalents for the six months ended December 31, 2015 and 2014, respectively, because they are anti-dilutive.</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline">Recent Accounting Pronouncements</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="TEXT-DECORATION: underline; DISPLAY: inline">Recently Adopted and Recently Issued Accounting Guidance</font></font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="TEXT-DECORATION: underline; DISPLAY: inline">Issued</font></font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">In January 2015, the FASB issued ASU 2015-01, &#x201c;Income Statement &#x2013; Extraordinary and Unusual Items (Subtopic 225-20),&#x201d; which eliminates the concept of extraordinary items. The new guidance is effective for fiscal years and interim periods within those years beginning after December&nbsp;15, 2015. The new guidance is to be applied prospectively but may also be applied retrospectively to all prior periods presented in the financial statements. Early adoption is permitted provided that the guidance is applied from the beginning of the fiscal year of adoption. We expect to adopt the provisions of this new guidance on July&nbsp;1, 2016. We do not expect the adoption of the new provisions to have a material impact on our financial condition or results of operations.</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">In November 2015, the FASB issued ASU No. 2015-17, &#x201c;Balance Sheet Classification of Deferred Taxes,&#x201d; requiring all deferred tax assets and liabilities, and any related valuation allowance, to be classified as noncurrent on the balance sheet. The classification change for all deferred taxes as noncurrent simplifies entities&#x2019; processes as it eliminates the need to separately identify the net current and net noncurrent deferred tax asset or liability in each jurisdiction and allocate valuation allowances. We do not expect the adoption of the new provisions to have a material impact on our financial condition or results of operations.</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">In July 2015, the FASB issued ASU No. 2015-11,&nbsp;&#x201c;Simplifying the Measurement of Inventory&#x201d;. Under ASU 2015-11, inventory will be measured at the &#x201c;lower of cost and net realizable value&#x201d; and options that currently exist for &#x201c;market value&#x201d; will be eliminated. The standard defines net realizable value as the &#x201c;estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.&#x201d; No other changes were made to the current guidance on inventory measurement. ASU 2015-11 is effective for interim and annual periods beginning after December&nbsp;15, 2016. Early application is permitted and should be applied prospectively. The Company is currently evaluating the impact the adoption of ASU 2015-11 will have on its financial statements.</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the SEC, did not, or are not believed by management to, have a material impact on the Company's present or future financial position, results of operations or cash flows.</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline">Related Party Transactions</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Amerityre&#x2019;s immediate past Chairman of the Board, Timothy L. Ryan, is also the principal owner of Rhino Rubber LLC, a manufacturing and distribution company for solid industrial tires and wheels.&nbsp;&nbsp;As of December 31, 2015, Mr. Ryan is no longer a director of the Company and all receivables outstanding to Rhino Rubber LLC have been reflected as trade accounts receivable.</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">We currently distribute directly from our manufacturing facility in Boulder City, Nevada only.&nbsp;&nbsp;In the past we also distributed from an independent, contracted warehouse in Ravenna, Ohio.&nbsp;&nbsp;This contract distribution point was unable to support customer requirements, became ineffective and stopped operations in the second quarter of 2014.&nbsp;&nbsp;In order to keep commitments to customers and keep revenue growth positive, distribution and other related services were transferred to Rhino Rubber in Akron, Ohio.&nbsp;&nbsp;The Company paid $600 for monthly warehousing fees inclusive of freight, shipping and labor for mounting services through October 31, 2015.&nbsp;&nbsp;Effective October 31, 2015 we closed the Akron, Ohio distribution point and customers are serviced on a direct basis.</font> </div><br/> <div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline">Reclassifications</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Certain reclassifications, which have no effect on net loss, have been made in the prior period financial statements, specifically the recognition of the preferred share dividend as a non-cash transaction at December 31, 2014.</font></div> <div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline">Trade Receivables</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">We generally charge-off trade receivables that are more than 120 days outstanding as bad-debt expense, unless management believes the amount to be collectable. The charge-off amounts are included in general and administrative expenses.&nbsp;As of December 31, 2015 and 2014, the reserve for uncollectible accounts was $-0- and $7,296, respectively.</font></div> 0 7296 <div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline">Stock Based-Compensation Expense</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">We account for stock-based compensation under the provisions of Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) 718, <font style="FONT-STYLE: italic; DISPLAY: inline">Compensation &#x2013; Stock Compensation</font> (ASC 718).&nbsp;&nbsp;Our financial statements as of and for the quarters ended December 31, 2015 and 2014 reflect the impact of ASC 718.&nbsp;&nbsp;Stock-based compensation expense related to director, employee or consultant options recognized under ASC 718 for the six months ended December 31, 2015 and 2014 was $41,795 and $13,571, respectively.</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">ASC 718 requires companies to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model.&nbsp;&nbsp;The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in our Statement of Operations.&nbsp;&nbsp;Stock-based compensation expense recognized in our Statements of Operations for the six months ended December 31, 2015 and 2014 assumes all awards will vest; therefore no reduction has been made for estimated forfeitures.&nbsp;&nbsp;We have awarded some options with a performance requirement and no amounts will be recorded until the requirement is met.</font></div> <div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline">Basic and Fully Diluted Net Loss Per Share</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Basic and Fully Diluted net loss per share is computed using the weighted-average number of common shares outstanding during the period.</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Our outstanding stock options and warrants and shares issuable upon conversion of outstanding convertible notes have been excluded from the basic and fully diluted net loss per share calculation.&nbsp;&nbsp;We excluded 3,700,000 and 2,834,000 common stock equivalents for the six months ended December 31, 2015 and 2014, respectively, because they are anti-dilutive.</font></div> 3700000 2834000 <div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline">Recent Accounting Pronouncements</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="TEXT-DECORATION: underline; DISPLAY: inline">Recently Adopted and Recently Issued Accounting Guidance</font></font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="TEXT-DECORATION: underline; DISPLAY: inline">Issued</font></font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">In January 2015, the FASB issued ASU 2015-01, &#x201c;Income Statement &#x2013; Extraordinary and Unusual Items (Subtopic 225-20),&#x201d; which eliminates the concept of extraordinary items. The new guidance is effective for fiscal years and interim periods within those years beginning after December&nbsp;15, 2015. The new guidance is to be applied prospectively but may also be applied retrospectively to all prior periods presented in the financial statements. Early adoption is permitted provided that the guidance is applied from the beginning of the fiscal year of adoption. We expect to adopt the provisions of this new guidance on July&nbsp;1, 2016. We do not expect the adoption of the new provisions to have a material impact on our financial condition or results of operations.</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">In November 2015, the FASB issued ASU No. 2015-17, &#x201c;Balance Sheet Classification of Deferred Taxes,&#x201d; requiring all deferred tax assets and liabilities, and any related valuation allowance, to be classified as noncurrent on the balance sheet. The classification change for all deferred taxes as noncurrent simplifies entities&#x2019; processes as it eliminates the need to separately identify the net current and net noncurrent deferred tax asset or liability in each jurisdiction and allocate valuation allowances. We do not expect the adoption of the new provisions to have a material impact on our financial condition or results of operations.</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">In July 2015, the FASB issued ASU No. 2015-11,&nbsp;&#x201c;Simplifying the Measurement of Inventory&#x201d;. Under ASU 2015-11, inventory will be measured at the &#x201c;lower of cost and net realizable value&#x201d; and options that currently exist for &#x201c;market value&#x201d; will be eliminated. The standard defines net realizable value as the &#x201c;estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.&#x201d; No other changes were made to the current guidance on inventory measurement. ASU 2015-11 is effective for interim and annual periods beginning after December&nbsp;15, 2016. Early application is permitted and should be applied prospectively. The Company is currently evaluating the impact the adoption of ASU 2015-11 will have on its financial statements.</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the SEC, did not, or are not believed by management to, have a material impact on the Company's present or future financial position, results of operations or cash flows.</font></div> <div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline">Related Party Transactions</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Amerityre&#x2019;s immediate past Chairman of the Board, Timothy L. Ryan, is also the principal owner of Rhino Rubber LLC, a manufacturing and distribution company for solid industrial tires and wheels.&nbsp;&nbsp;As of December 31, 2015, Mr. Ryan is no longer a director of the Company and all receivables outstanding to Rhino Rubber LLC have been reflected as trade accounts receivable.</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">We currently distribute directly from our manufacturing facility in Boulder City, Nevada only.&nbsp;&nbsp;In the past we also distributed from an independent, contracted warehouse in Ravenna, Ohio.&nbsp;&nbsp;This contract distribution point was unable to support customer requirements, became ineffective and stopped operations in the second quarter of 2014.&nbsp;&nbsp;In order to keep commitments to customers and keep revenue growth positive, distribution and other related services were transferred to Rhino Rubber in Akron, Ohio.&nbsp;&nbsp;The Company paid $600 for monthly warehousing fees inclusive of freight, shipping and labor for mounting services through October 31, 2015.&nbsp;&nbsp;Effective October 31, 2015 we closed the Akron, Ohio distribution point and customers are serviced on a direct basis.</font></div> 600 <div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">NOTE 3 - INVENTORY</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Inventory is stated at the lower of cost (computed on a first-in, first-out basis) or net realizable value.&nbsp;&nbsp;The inventory consists primarily of chemicals, finished goods produced in our plant and products purchased for resale.</font> </div><br/><table cellpadding="0" cellspacing="0" width="75%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" width="47%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td colspan="2" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">December 31, 2015</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td colspan="2" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">June 30, 2015</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> </tr> <tr> <td align="left" valign="bottom" width="47%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td align="left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td colspan="2" valign="bottom" width="12%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">(Unaudited)</font> </div> </td> <td align="left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td align="left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td align="left" colspan="2" valign="bottom" width="12%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td align="left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> </tr> <tr style="background-color: #cceeff;"> <td valign="bottom" width="47%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Raw Materials</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font> </div> </div> </td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">272,689</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font> </div> </div> </td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">302,910</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> </tr> <tr> <td valign="bottom" width="47%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Finished Goods</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">695,243</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">655,714</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> </tr> <tr style="background-color: #cceeff;"> <td valign="bottom" width="47%" style="PADDING-BOTTOM: 2px"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Inventory reserve</font> </div> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">(126,142</font> </div> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">)</font> </div> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">(110,935</font> </div> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">)</font> </div> </div> </td> </tr> <tr> <td valign="bottom" width="47%" style="PADDING-BOTTOM: 4px"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Inventory - net</font> </div> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font> </div> </div> </td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">841,790</font> </div> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">847,689</font> </div> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> </tr> </table><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Our inventory reserve reflects items that were deemed to be slow moving or obsolete based on an analysis of all inventories on hand.</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">The Company critically reviews all slow moving inventory to determine if defective or obsolete.&nbsp;&nbsp;If not defective or obsolete, but slow moving, we present these items as non-current inventory, although all inventory is ready and available for sale at any moment.&nbsp;&nbsp;</font> </div><br/> Inventory is stated at the lower of cost (computed on a first-in, first-out basis) or net realizable value. The inventory consists primarily of chemicals, finished goods produced in our plant and products purchased for resale. <br /> <br /><table cellpadding="0" cellspacing="0" width="75%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" width="47%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td colspan="2" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">December 31, 2015</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td colspan="2" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">June 30, 2015</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> </tr> <tr> <td align="left" valign="bottom" width="47%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td align="left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td colspan="2" valign="bottom" width="12%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">(Unaudited)</font> </div> </td> <td align="left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td align="left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td align="left" colspan="2" valign="bottom" width="12%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td align="left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> </tr> <tr style="background-color: #cceeff;"> <td valign="bottom" width="47%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Raw Materials</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font> </div> </div> </td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">272,689</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font> </div> </div> </td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">302,910</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> </tr> <tr> <td valign="bottom" width="47%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Finished Goods</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">695,243</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">655,714</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> </tr> <tr style="background-color: #cceeff;"> <td valign="bottom" width="47%" style="PADDING-BOTTOM: 2px"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Inventory reserve</font> </div> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">(126,142</font> </div> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">)</font> </div> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">(110,935</font> </div> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">)</font> </div> </div> </td> </tr> <tr> <td valign="bottom" width="47%" style="PADDING-BOTTOM: 4px"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Inventory - net</font> </div> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font> </div> </div> </td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">841,790</font> </div> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">847,689</font> </div> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> </tr> </table> 272689 302910 695243 655714 126142 110935 841790 847689 <div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">NOTE 4&nbsp;- CAPITAL LEASE</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">In July 2015 the Company entered into a capital lease for research and development equipment for $19,337.</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">The following is a schedule by years of future minimum lease payments under capital leases together with present value of the net minimum lease payments as of December 31, 2015:</font> </div><br/><table cellpadding="0" cellspacing="0" width="75%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr style="background-color: #cceeff;"> <td align="right" valign="bottom" width="61%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">2016</font> </div> </td> <td align="right" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">4,349</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> <tr> <td align="right" valign="bottom" width="61%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">2017</font> </div> </td> <td align="right" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">8,697</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> <tr style="background-color: #cceeff;"> <td align="right" valign="bottom" width="61%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">2018</font> </div> </td> <td align="right" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">8,697</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> <tr> <td align="right" valign="bottom" width="61%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">2019</font> </div> </td> <td align="right" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">725</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> <tr style="background-color: #cceeff;"> <td align="right" valign="bottom" width="61%" style="PADDING-BOTTOM: 2px"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">2020</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">-</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> <tr> <td align="right" valign="bottom" width="61%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Total minimum lease payments</font> </div> </td> <td align="right" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">22,468</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> <tr style="background-color: #cceeff;"> <td align="right" valign="bottom" width="61%" style="PADDING-BOTTOM: 2px"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Less:&nbsp;&nbsp;executory costs</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">-</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> <tr> <td align="right" valign="bottom" width="61%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Net minimum lease payments</font> </div> </td> <td align="right" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">22,468</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> <tr style="background-color: #cceeff;"> <td align="right" valign="bottom" width="61%" style="PADDING-BOTTOM: 2px"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Less:&nbsp;&nbsp;amount representing interest</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">5,149</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> <tr> <td align="right" valign="bottom" width="61%" style="PADDING-BOTTOM: 4px"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Present value of net minimum payments</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">17,319</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> </table><br/> 19337 The following is a schedule by years of future minimum lease payments under capital leases together with present value of the net minimum lease payments as of December 31, 2015: <br /> <br /><table cellpadding="0" cellspacing="0" width="75%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr style="background-color: #cceeff;"> <td align="right" valign="bottom" width="61%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">2016</font> </div> </td> <td align="right" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">4,349</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> <tr> <td align="right" valign="bottom" width="61%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">2017</font> </div> </td> <td align="right" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">8,697</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> <tr style="background-color: #cceeff;"> <td align="right" valign="bottom" width="61%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">2018</font> </div> </td> <td align="right" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">8,697</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> <tr> <td align="right" valign="bottom" width="61%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">2019</font> </div> </td> <td align="right" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">725</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> <tr style="background-color: #cceeff;"> <td align="right" valign="bottom" width="61%" style="PADDING-BOTTOM: 2px"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">2020</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">-</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> <tr> <td align="right" valign="bottom" width="61%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Total minimum lease payments</font> </div> </td> <td align="right" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">22,468</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> <tr style="background-color: #cceeff;"> <td align="right" valign="bottom" width="61%" style="PADDING-BOTTOM: 2px"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Less:&nbsp;&nbsp;executory costs</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">-</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> <tr> <td align="right" valign="bottom" width="61%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Net minimum lease payments</font> </div> </td> <td align="right" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">22,468</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> <tr style="background-color: #cceeff;"> <td align="right" valign="bottom" width="61%" style="PADDING-BOTTOM: 2px"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Less:&nbsp;&nbsp;amount representing interest</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">5,149</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> <tr> <td align="right" valign="bottom" width="61%" style="PADDING-BOTTOM: 4px"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Present value of net minimum payments</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">17,319</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> </table> 4349 8697 8697 725 0 22468 0 22468 5149 17319 <div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">NOTE 5&nbsp;- STOCK TRANSACTIONS</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">In July 2015 the Board of Directors granted the following stock bonus awards:</font> </div><br/><table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="WIDTH: 36pt"> <div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-SIZE: 10pt; DISPLAY: inline">&middot;&nbsp;&nbsp;</font></font> </div> </td> <td> <div align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-SIZE: 10pt; DISPLAY: inline">To all non-officer employees of Amerityre on record as of July 22, 2015, a one-time stock bonus award of 5,000 shares of the Company&#x2019;s restricted common stock per employee, valued at $0.015 a share (fair value on the date of grant with a 50% discount pursuant to U.S. Internal Revenue Service, revenue Ruling 77-287).&nbsp;&nbsp;As of July 22, 2015 there were 16 non-officer employees at Amerityre resulting in 80,000 shares, which were issued in July 2015.</font></font> </div> </td> </tr> </table><br/><table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent-0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="WIDTH: 36pt"> <div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-SIZE: 10pt; DISPLAY: inline">&middot;&nbsp;&nbsp;</font></font> </div> </td> <td> <div align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="FONT-SIZE: 10pt; DISPLAY: inline">To the officers of Amerityre, 600,000 shares were granted on July 20, 2015 (valued at $0.03) with 75% of the grant allocated to the CEO and 25% of the grant allocated to the CFO.&nbsp;&nbsp;The shares of stock vest ratably each quarter end during fiscal year 2016 and are payable immediately after the vesting date.&nbsp;&nbsp;For the six months ended December 31, 2015 the Company recognized $9,000 of compensation expense for these grants; $4,500 of which is a stock payable.</font></font> </div> </td> </tr> </table><br/> 5000 0.015 0.50 80000 600000 0.03 0.75 0.25 9000 4500 <div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">NOTE&nbsp;6 - STOCK OPTIONS AND WARRANTS</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline">General Option Information</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">On July 6, 2011, the Board of Directors cancelled the &#x201c;2004 Non-Employee Directors&#x2019; Stock Incentive Plan&#x201d; and approved the "Directors&#x2019; 2011 Stock Option and Award Plan&#x201d;.&nbsp;&nbsp; Under the 2011 Plan, a total of 3,300,000 shares are authorized for issuance.</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">The Company also maintained the 2005 Stock Option and Award Plan, which was previously approved by shareholders, for the purpose of granting option awards to its employees and consultants.&nbsp;&nbsp;&nbsp;This plan had a 10 year life and expired July 2015.</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">On August 10, 2015, the Board of Directors cancelled the &#x201c;Directors&#x2019; 2011 Stock Option and Award Plan&#x201d; as all options under this plan had been granted and adopted the &#x201c;2015 Omnibus Stock Option and Award Plan&#x201d; which contains provisions for up to 3,000,000 stock options to be granted to employees, consultants and directors.&nbsp;&nbsp;The 2015 Omnibus Stock Option and Award Plan did not obtain the necessary shareholder approval in the Company&#x2019;s annual proxy process, resulting in certain U.S. Internal Revenue Service provisions to be ineffective.</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"><font style="TEXT-DECORATION: underline; DISPLAY: inline">Option issuances and vesting during the six month period ending December 31, 2015</font></font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">On December 1, 2014, 480,000 options were granted to the Company&#x2019;s Chief Executive Officer (then our Chief Operating Officer) as part of his employment offer.&nbsp;&nbsp;The options have a strike price of $0.10, vest December 1, 2015 and expire December 1, 2020.&nbsp;&nbsp;Year to date expense related to these options is $7,746 as of December 31, 2015.&nbsp;</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">On January 21, 2015, 50,000 options were granted to the Company&#x2019;s Chief Financial Officer as part of her employment offer.&nbsp;&nbsp;The options have a strike price of $0.10, vest ratably January 21, 2015 to December 1, 2015 and expire December 1, 2018.&nbsp;&nbsp;Year to date expense related to these options is $840 as of December 31, 2015.</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">In the October 2015 Board meeting, the Board granted all non-executive Board members 100,000 options, with the audit committee chair receiving an additional 50,000 options, for Board services rendered for the fiscal year ended June 30, 2015.&nbsp;&nbsp;The options have a strike price of $0.10, vest at the end of the Board term on December 3, 2015 and expire December 3, 2017.&nbsp;&nbsp;Expense related to these options is $21,950 as of December 31, 2015.</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">On December 1, 2015, 480,000 options were granted to the Company&#x2019;s Chief Executive Officer (then our Chief Operating Officer) as part of his employment offer.&nbsp;&nbsp;The options have a strike price of $0.10, vest December 1, 2016 and expire December 1, 2020.&nbsp;&nbsp;Year to date expense related to these options is $1,060 as of December 31, 2015.&nbsp;</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">As of December 31, 2015, there was $11,655 of unrecognized stock-based compensation expense related to stock options that will be recognized over the vest period of the underlying option.</font> </div><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">We estimated the fair value of the stock options above at the grant date based on the following weighted average assumptions:</font> </div><br/><table cellpadding="0" cellspacing="0" width="75%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr style="background-color: #cceeff;"> <td valign="bottom" width="57%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Risk free interest rate</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">1.155</font></td> <td valign="bottom" width="5%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">%&nbsp;</font> </div> </div> </td> </tr> <tr> <td valign="bottom" width="57%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Expected life</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">2.0 &#x2013; 4.5</font></td> <td valign="bottom" width="5%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;years&nbsp;</font> </div> </div> </td> </tr> <tr style="background-color: #cceeff;"> <td valign="bottom" width="57%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Expected volatility</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">167.37 &#x2013; 113.50</font></td> <td valign="bottom" width="5%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">%&nbsp;</font> </div> </div> </td> </tr> <tr> <td valign="bottom" width="57%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Dividend yield</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.00</font></td> <td valign="bottom" width="5%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">%&nbsp;</font> </div> </div> </td> </tr> </table><br/><div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">A summary of the status of our outstanding stock options as of December 31, 2015 and June 30, 2015 and changes during the periods then ended is presented below:</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">December 31, 2015</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">June 30, 2015</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> </tr> <tr> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Weight Average</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Intrinsic</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Weight Average</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td align="left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom" style="TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Intrinsic</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Shares</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Exercise Price</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Value</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Shares</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Exercise Price</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Value</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> <tr style="background-color: #cceeff;"> <td align="left" valign="bottom"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Outstanding beginning of period</font> </div> </td> <td align="right" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">2,270,000</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.14</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td align="right" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">1,754,000</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.17</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> <tr> <td align="left" valign="bottom"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Granted</font> </div> </td> <td align="right" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">1,030,000</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.10</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td align="right" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">670,000</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.10</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> <tr style="background-color: #cceeff;"> <td align="left" valign="bottom"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Expired/Cancelled</font> </div> </td> <td align="right" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">-</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.00</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td align="right" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">(154,000</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">)</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">(0.29</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">)</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Exercised</font> </div> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">-</font></td> <td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.00</font></td> <td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">-</font></td> <td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.00</font></td> <td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> <tr style="background-color: #cceeff;"> <td align="left" valign="bottom" width="16%" style="PADDING-BOTTOM: 4px"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Outstanding end of period</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">3,300,000</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.13</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">132,000</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">2,270,000</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.14</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">45,400</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> <tr> <td align="left" valign="bottom" width="16%" style="PADDING-BOTTOM: 4px"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Exercisable</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">2,820,000</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.13</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">112,800</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">1,752,500</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.16</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">35,050</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> </table><br/><div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">The intrinsic value of outstanding and exercisable shares is based on the closing price of the Company&#x2019;s common stock of $0.04 per share on December 31, 2015 ($0.02 per share on June 30, 2015), the last trading day of the quarter.</font> </div><br/><div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">The following table summarizes the range of outstanding and exercisable options as of December 31, 2015:</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Outstanding</font> </div> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Exercisable</font> </div> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> </tr> <tr> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font> </div> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Range of</font> </div> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Exercise Prices</font> </div> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Number Outstanding</font> </div> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">at</font> </div> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">December 31, 2015</font> </div> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Weighted</font> </div> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Average</font> </div> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Remaining</font> </div> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Contractual Life</font> </div> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font> </div> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Weighted</font> </div> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Average</font> </div> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Exercise Price</font> </div> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font> </div> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Number</font> </div> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Exercisable at</font> </div> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">December 31, 2015</font> </div> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Weighted</font> </div> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Average Remaining</font> </div> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Contractual Life</font> </div> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> </tr> <tr style="background-color: #cceeff;"> <td valign="bottom" width="1%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font> </div> </div> </td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.08</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">150,000</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">5.92</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font> </div> </div> </td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.08</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">150,000</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">5.92</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> </tr> <tr> <td valign="bottom" width="1%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font> </div> </div> </td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.10</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">1,700,000</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">3.96</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font> </div> </div> </td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.10</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">1,220,000</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">3.96</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> </tr> <tr style="background-color: #cceeff;"> <td valign="bottom" width="1%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font> </div> </div> </td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.17</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">650,000</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">3.92</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font> </div> </div> </td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.17</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">650,000</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">3.92</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> </tr> <tr> <td valign="bottom" width="1%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font> </div> </div> </td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.17</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">400,000</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">4.92</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font> </div> </div> </td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.17</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">400,000</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">4.92</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> </tr> <tr style="background-color: #cceeff;"> <td valign="bottom" width="1%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font> </div> </div> </td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 2px"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.17</font> </div> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">400,000</font> </div> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 2px"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">5.92</font> </div> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font> </div> </div> </td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 2px"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.17</font> </div> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">400,000</font> </div> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 2px"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">5.92</font> </div> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> </tr> <tr> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">3,300,000</font> </div> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">2,820,000</font> </div> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> </tr> </table><br/><div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline">General Warrant Information</font> </div><br/><div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">In September 2013, the Company obtained an extension on the remaining $100,000 secured convertible promissory note that was issued in the private placement that closed in September 2010.&nbsp;&nbsp;This note was paid off as of June 30, 2015.&nbsp;&nbsp; In exchange for the extension, the note holder received 500,000 common stock warrants and $6,500 in accrued interest and fees.&nbsp;&nbsp;The common stock warrants expire three years from the date of issuance, are exercisable at $0.13 per share, and vest on the next date the value of Amerityre common stock reaches $0.25 per share.&nbsp;&nbsp;As of December 31, 2015 the warrants have not vested.</font> </div><br/> 3300000 P10Y 3000000 480000 0.10 2015-12-01 2020-12-01 7746 50000 0.10 2015-01-21 2015-12-01 2018-12-01 840 100000 50000 0.10 2015-12-03 2017-12-03 21950 480000 0.10 2016-12-01 2020-12-01 1060 11655 0.04 0.02 100000 500000 6500 P3Y 0.13 0.25 We estimated the fair value of the stock options above at the grant date based on the following weighted average assumptions: <br /> <br /><table cellpadding="0" cellspacing="0" width="75%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr style="background-color: #cceeff;"> <td valign="bottom" width="57%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Risk free interest rate</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">1.155</font></td> <td valign="bottom" width="5%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">%&nbsp;</font> </div> </div> </td> </tr> <tr> <td valign="bottom" width="57%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Expected life</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">2.0 &#x2013; 4.5</font></td> <td valign="bottom" width="5%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;years&nbsp;</font> </div> </div> </td> </tr> <tr style="background-color: #cceeff;"> <td valign="bottom" width="57%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Expected volatility</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">167.37 &#x2013; 113.50</font></td> <td valign="bottom" width="5%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">%&nbsp;</font> </div> </div> </td> </tr> <tr> <td valign="bottom" width="57%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Dividend yield</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.00</font></td> <td valign="bottom" width="5%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">%&nbsp;</font> </div> </div> </td> </tr> </table> 0.01155 P2Y P4Y6M 1.6737 1.1350 0.0000 A summary of the status of our outstanding stock options as of December 31, 2015 and June 30, 2015 and changes during the periods then ended is presented below: <br /> <br /><table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">December 31, 2015</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">June 30, 2015</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> </tr> <tr> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Weight Average</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Intrinsic</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Weight Average</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td align="left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom" style="TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Intrinsic</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Shares</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Exercise Price</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Value</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Shares</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Exercise Price</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Value</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> <tr style="background-color: #cceeff;"> <td align="left" valign="bottom"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Outstanding beginning of period</font> </div> </td> <td align="right" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">2,270,000</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.14</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td align="right" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">1,754,000</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.17</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> <tr> <td align="left" valign="bottom"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Granted</font> </div> </td> <td align="right" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">1,030,000</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.10</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td align="right" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">670,000</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.10</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> <tr style="background-color: #cceeff;"> <td align="left" valign="bottom"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Expired/Cancelled</font> </div> </td> <td align="right" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">-</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.00</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td align="right" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">(154,000</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">)</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" style="TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">(0.29</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">)</font></td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Exercised</font> </div> </td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">-</font></td> <td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.00</font></td> <td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td align="right" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">-</font></td> <td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.00</font></td> <td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> <tr style="background-color: #cceeff;"> <td align="left" valign="bottom" width="16%" style="PADDING-BOTTOM: 4px"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Outstanding end of period</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">3,300,000</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.13</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">132,000</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">2,270,000</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.14</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">45,400</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> <tr> <td align="left" valign="bottom" width="16%" style="PADDING-BOTTOM: 4px"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">Exercisable</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">2,820,000</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.13</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">112,800</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">1,752,500</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.16</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font></td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">35,050</font></td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> </tr> </table> 2270000 0.14 1754000 0.17 1030000 0.10 670000 0.10 0 0.00 154000 0.29 0 0.00 0 0 0.00 0 3300000 0.13 132000 45400 2820000 0.13 112800 1752500 0.16 35050 The following table summarizes the range of outstanding and exercisable options as of December 31, 2015: <br /> <br /><table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp;</font></td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Outstanding</font> </div> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Exercisable</font> </div> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> </tr> <tr> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font> </div> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Range of</font> </div> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Exercise Prices</font> </div> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Number Outstanding</font> </div> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">at</font> </div> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">December 31, 2015</font> </div> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Weighted</font> </div> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Average</font> </div> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Remaining</font> </div> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Contractual Life</font> </div> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font> </div> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Weighted</font> </div> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Average</font> </div> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Exercise Price</font> </div> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font> </div> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Number</font> </div> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Exercisable at</font> </div> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">December 31, 2015</font> </div> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Weighted</font> </div> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Average Remaining</font> </div> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="center"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline">Contractual Life</font> </div> </td> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> </tr> <tr style="background-color: #cceeff;"> <td valign="bottom" width="1%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font> </div> </div> </td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.08</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">150,000</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">5.92</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font> </div> </div> </td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.08</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">150,000</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">5.92</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> </tr> <tr> <td valign="bottom" width="1%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font> </div> </div> </td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.10</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">1,700,000</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">3.96</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font> </div> </div> </td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.10</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">1,220,000</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">3.96</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> </tr> <tr style="background-color: #cceeff;"> <td valign="bottom" width="1%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font> </div> </div> </td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.17</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">650,000</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">3.92</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font> </div> </div> </td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.17</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">650,000</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">3.92</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> </tr> <tr> <td valign="bottom" width="1%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font> </div> </div> </td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.17</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">400,000</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">4.92</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font> </div> </div> </td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.17</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">400,000</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">4.92</font> </div> </div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> </tr> <tr style="background-color: #cceeff;"> <td valign="bottom" width="1%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font> </div> </div> </td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 2px"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.17</font> </div> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">400,000</font> </div> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 2px"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">5.92</font> </div> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">$</font> </div> </div> </td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 2px"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">0.17</font> </div> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">400,000</font> </div> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 2px"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">5.92</font> </div> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> </tr> <tr> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">3,300,000</font> </div> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="right"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">2,820,000</font> </div> </div> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="11%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline">&nbsp; </font></td> </tr> </table> 0.08 150000 P5Y335D 0.08 150000 P5Y335D 0.10 1700000 P3Y350D 0.10 1220000 P3Y350D 0.17 650000 P3Y335D 0.17 650000 P3Y335D 0.17 400000 P4Y335D 0.17 400000 P4Y335D 0.17 400000 P5Y335D 0.17 400000 P5Y335D <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">NOTE&nbsp;7&nbsp;- LIQUIDITY</font> </div><br/><div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">Over the past year, we have been working on various proposals to secure short-term loans as well as long-term bank financing and equity based investments.&nbsp;The Company currently does not have an existing credit facility.&nbsp;Over the past year, we have worked with our vendors to obtain extended credit terms and increase credit lines where needed.&nbsp;Additionally, we continue to focus on adherence to established collection policies and proactive communication with repeat customers, including adjusting credit limits to allow for increased sales volume where warranted.</font> </div><br/><div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">We are intent on focusing on the sale and distribution of profitable product lines.&nbsp;Management continues to look for further financing facilities at affordable terms that will allow the Company to maintain sufficient raw material and finished goods inventory to capitalize on sales growth opportunities. No additional capital expenditures are anticipated over the next twelve months unless they support sales development and product improvement.&nbsp;&nbsp;We continue to work to reduce our overall costs wherever possible.</font> </div><br/><div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">To help address our cash resources which at times may be limited, we are in discussions with various third parties about potential opportunities to license our technology which we believe will bring in additional cash flows without diluting our common stock or requiring the addition of debt. We are in discussions with banks and other lenders regarding establishing a line of credit for short term cash needs, however at this time we have not succeeded in establishing such a line of credit.&nbsp;&nbsp;Lastly, we have entered into a short term receivable factoring agreement with a third party to sell our receivable invoices.&nbsp;&nbsp;This agreement enables us to sell individual customer invoices for faster cash flow to the Company as we deem needed.</font> </div><br/><div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">As of December 31, 2015, the Company has approximately 7,064,000 shares authorized and available for issuance. Although we are reluctant to raise money through stock sales at what we believe are dilutive share prices,&nbsp;these authorized but unissued and unreserved shares of our common stock can be utilized if necessary to fund the expansion of our manufacturing operations or to obtain additional working capital.</font> </div><br/><div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">The Company has also instituted initiatives to incentivize sales of slower moving inventory through promotional pricing. These programs will continue to be utilized in the upcoming quarters to monetize inventory and improve our cash flow.</font> </div><br/><div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">In assessing our liquidity, management reviews and analyzes our current cash, accounts receivable, accounts payable, capital expenditure commitments and other obligations.&nbsp;&nbsp;In connection with the preparation of our financial statements for the period ended December 31, 2015, we have analyzed our cash needs for the next twelve months.&nbsp;We have concluded that our available cash and accounts receivables are sufficient to meet our current minimum working capital, capital expenditure and other cash requirements for this period.</font> </div><br/> 7064000 <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline">NOTE&nbsp;8&nbsp;- SUBSEQUENT EVENTS</font> </div><br/><div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">On January 19, 2016, the Board granted all non-executive Board members 100,000 options, with the audit committee chair receiving an additional 50,000 options, for Board services rendered for the fiscal year ended June 30, 2016.&nbsp;&nbsp;The options have a strike price of $0.10, vest at the end of the Board term in December 2016 and expire December 2019.&nbsp;&nbsp;</font> </div><br/><div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">On January 19, 2016, 50,000 options were granted to the Company&#x2019;s Chief Financial Officer as part of renewal of her employment agreement.&nbsp;&nbsp;The options have a strike price of $0.10, vest ratably January 21, 2016 to December 1, 2016 and expire December 1, 2019.&nbsp;&nbsp;In addition to the option renewal $550 a month in health insurance reimbursement was included in the renewal.&nbsp;&nbsp;All other terms remain the same.</font> </div><br/><div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" align="left"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline">In January 2016, 150,000 shares that had vested at December 31, 2015 for the CEO and CFO were issued.</font> </div><br/> 100000 50000 0.10 50000 0.10 vest ratably January 21, 2016 to December 1, 2016 2019-12-01 550 150000 EX-101.SCH 7 amty-20151231.xsd EX-101.SCH 001 - Statement - Balance Sheets link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Disclosure - NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION link:presentationLink link:definitionLink link:calculationLink 006 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - NOTE 3 - INVENTORY link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - NOTE 4 - CAPITAL LEASE link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - NOTE 5 - STOCK TRANSACTIONS link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - NOTE 7 - LIQUIDITY link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - NOTE 8 - SUBSEQUENT EVENTS link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - NOTE 3 - INVENTORY (Tables) link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - NOTE 4 - CAPITAL LEASE (Tables) link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Tables) link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - NOTE 3 - INVENTORY (Details) - Schedule of Inventory link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - NOTE 4 - CAPITAL LEASE (Details) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - NOTE 4 - CAPITAL LEASE (Details) - Schedule of Capital Leased Assets link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - NOTE 5 - STOCK TRANSACTIONS (Details) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Valuation Assumptions link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Stock Options, Activity link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - NOTE 7 - LIQUIDITY (Details) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - NOTE 8 - SUBSEQUENT EVENTS (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Disclosure - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 amty-20151231_cal.xml EX-101.CAL EX-101.DEF 9 amty-20151231_def.xml EX-101.DEF EX-101.LAB 10 amty-20151231_lab.xml EX-101.LAB EX-101.PRE 11 amty-20151231_pre.xml EX-101.PRE GRAPHIC 12 logo.jpg GRAPHIC begin 644 logo.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_X0!F17AI9@ 34T *@ @ ! $: 4 M ! /@$; 4 ! 1@$H , ! ( $Q ( 0 3@ M !@ 0 & !4&%I;G0N3D54('8U+C P /_; $, @$! @$! M @(" @(" @(#!0,# P,#!@0$ P4'!@<'!P8'!P@)"PD(" H(!P<*#0H*"PP, M# P'"0X/#0P."PP,#/_; $,! @(" P,#!@,#!@P(!P@,# P,# P,# P,# P, M# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_ !$( %D M60,!(@ "$0$#$0'_Q ? !!0$! 0$! 0 0(#! 4&!P@)"@O_ MQ "U$ " 0,# @0#!04$! 7T! @, !!$%$B$Q008346$'(G$4,H&1H0@C M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-CH.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X M^?K_Q ? 0 # 0$! 0$! 0$! 0(#! 4&!P@)"@O_Q "U$0 " 0($ M! ,$!P4$! ! G< 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B M7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X MN;K"P\3%QL?(RKR\_3U]O?X^?K_V@ , P$ M A$#$0 _ /W\HHSBB@ HHHH **-U&:+@%%&:-U%[;@%%%% !1110!7C7=3$+O6M4E\FSL1EC7#BL?1PM'V]8=&C=V-+7_$VG^& M]-FN[ZZAL[2 ?O9)3B$5X'X\_P""@FC:=<26OAG3YM8FQS=2?N;?\Z^7_C5^ MT+X@_:%\3^;?S7%GH]O-_H6G1?ZC_MM6Q\)_AS=>/?$UGI5C'B6;J?\ GWK\ M'QWBAC,PQOU+)S[[ \+T:5'ZQC3W;X3_ !$^(G[0OB=83?KHVCVYS=S6L.>? M^>->I?M"?M'>$_V1?@]J7B[QKJW]GZ/H<&6ED.9YN.(HAG][,<< =?SJ[!#X M=_9E^%5W>7US;Z;HFAVAO+R[E/"X!,LQ^M?@!_P4H_;L\0?\%%_C7-<1&^L_ M >@SF'0-)^O_ "VF_P"FTW0#L!7[-POEM>G0OC?XI^2\:<44,O\ X)^['[&G M[9W@3]NKX06OC'P3?RS6:/O>/"7CC2_'^ MBQ7FEWT%[:3=)8CUKX7^-7PFNOASXNO-/NO^6'^IE_Y[PUQWPZ^,/B#X">)O MM^A3?N3-_IMI*?W%_7X70\2L9E6-^I9D?L%?A>CBJ/M\$?IO]Y*;NKA?@K\9 M=+^-/@:SUO3#^Y(Q+"3^]MY>\1KN?F]J_>LOQ^'Q=%5J>S/AZM.5&7LZFZ%F M7+BOBW_@IE\1I+C7M#\*0X^QPQ&^N,>O2+]:^T@=R U\+?\ !2OPU-IGQ6T/ M5ED-7V)]!PA1HO,5[8\*\)6U?<_[%7PJ_X1OP3_ M ,)!=1?Z9JO,/_3"'M7QW\#?"LGCOQ[I.BQ\+?7GDG_KA7VU^UE\?-(_8V_9 M4\7^/+R"'[+X3TEKB"'_ )[S#B&+\92!^-?FW@CD?M?]MK'T''V;>RI>P1^9 MO_!PI_P4(E\1^,(?@3X8U#_1;'R;WQ7-%_RVE/,-C_*;\!7Q-\'?#=I;5J^+S+VK.V^+/A*TMM/F\FOHS_@A!_P % IO@#\?C M\)?$5\6\)>.KLC2_,_U-AJ7H/^N_'Z5\D_$C_A+/[/\ ]*\,^*K*'_GM-IDT M%>&ZUXEFTW4(9K6:>RO+>;SX9O\ EO;S4[_NC'+ZN,PF-]M1/ZEOVL?A7_PL M'P#)J%K$O]I:3^^AP?\ 71^E?!OBVVK[$_X)?_M91?MO?L0^#_&=S)%-JUU: M?V=K,8Z+>P?NI_S(_6OFK]J?P9_PKKXJZ[I7_+'SO/A_ZXS5_-7C=D=J/UVB M?V9X?YM[7]PSM/\ @G-\1)/#OQ>O/#YD_P!%UR'SQ%Z30]:^[=WTK\^_^">W MAJ76_P!H6TNHO]3I-E---]?]17Z!>37N>$>*QD\CBWW/+XPC0_M!^SV)1_JZ M\V_:0^!5K\?/AW=:5)^YO(OWUG-_SPF[&O2_NK2 KFOU[-LJHYA0="N?,T*] M6C556D?#_P"P?\']4\/_ +0>N1ZY8S6=UXOF\ER2CPYESI4#T,=B'F=:]8I?";]A# MX,_ 6".W\)?#/P=H?DC(N(-,A^T#_ML1YWZUZBU[I.GGR_.M(O;-?%?B'XD> M,/._XJ*;Q%!-_P \;O\ <5#;>-O^FU>-7\0I+3V)T8?@^AOH?;0O]*NAA9K. M3_MJ*X7XI?LB_"GXZ6,L/BSP+X/\0QS#D7FF0S2'\<9KY?N?&T/_ #VHT[Q_ MXF\__BG;O7)Y?^>-IYT]*AXB2?\ RY"MP?0\CZ)_9/\ V)OA[^Q7I>N:?\.= M)G\/Z7XAO?ML^G_;)9H(9L8_<^<3BO(_^"C?PXU#6O''A&ZTNTGO-1U0S6/E M1?2O6/V>?$_Q5U>_B_X2K2;"'22.)ILPWOXQ=JZGXD_$63P-JGS:/_:*V^FW M=]YHE'G8@YQ^->GG>'HY]EOL:YAE>3-KFI'S[ MV6,=3Q^Z_"O9_(7UKB/A-\7K/XK#4OL-K<0PZ>T40FE_Y;9KL?-_SFOU-![:L]QWEX[53N--ANA^]AAFK0 MHKI]@C&Y1T[3H;!?W<,,/_7,5:Q3PN*6IA15@"BBBND HHHH *,444 &*,44 ,4 %%%% !1110!__9 end XML 13 R1.htm IDEA: XBRL DOCUMENT v3.3.1.900
Document And Entity Information - shares
 6 Months Ended
Dec. 31, 2015
Feb. 08, 2016
Document and Entity Information [Abstract]    
Entity Registrant Name Amerityre Corp  
Document Type 10-Q  
Current Fiscal Year End Date --06-30  
Entity Common Stock, Shares Outstanding   41,950,287
Amendment Flag false  
Entity Central Index Key 0000945828  
Entity Current Reporting Status Yes  
Entity Voluntary Filers No  
Entity Filer Category Smaller Reporting Company  
Entity Well-known Seasoned Issuer No  
Document Period End Date Dec. 31, 2015  
Document Fiscal Year Focus 2016  
Document Fiscal Period Focus Q2  
XML 14 R2.htm IDEA: XBRL DOCUMENT v3.3.1.900
Balance Sheets - USD ($)
Dec. 31, 2015
Jun. 30, 2015
CURRENT ASSETS    
Cash $ 156,288 $ 455,717
Accounts receivable - net 312,891 314,054
Accounts receivable - related party 0 6,312
Inventory - net 646,012 661,129
Prepaid and other current assets 96,128 27,860
Total Current Assets 1,211,319 1,465,072
PROPERTY AND EQUIPMENT    
Leasehold improvements 153,543 153,543
Molds and models 572,894 572,894
Equipment 2,964,900 2,937,922
Furniture and fixtures 74,921 74,921
Software 305,924 305,924
Less - accumulated depreciation (3,803,107) (3,735,744)
Total Property and Equipment 269,075 309,460
OTHER ASSETS    
Patents and trademarks - net 189,045 202,710
Non-current inventory 195,778 186,560
Deposits 11,000 11,000
Total Other Assets 395,823 400,270
TOTAL ASSETS 1,876,217 2,174,802
CURRENT LIABILITIES    
Accounts payable and accrued expenses 438,664 438,680
Current portion of long-term debt 12,441 13,608
Current portion of lease liability 5,642 0
Total Current Liabilities 456,747 452,288
Long-term debt 53,840 53,840
Long-term lease liability 11,677 0
Total Long-Term Liabilities 65,517 53,840
TOTAL LIABILITIES 522,264 506,128
STOCKHOLDERS' EQUITY    
Preferred stock: 5,000,000 shares authorized of $0.001 par value, 2,000,000 shares issued and outstanding, respectively 2,000 2,000
Common stock: 75,000,000 shares authorized of $0.001 par value, 41,800,287 and 41,441,620 shares Issued and outstanding, respectively 41,800 41,570
Additional paid-in capital 62,552,922 62,515,856
Stock payable 4,500 0
Accumulated deficit (61,247,269) (60,890,752)
Total Stockholders' Equity 1,353,953 1,668,674
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 1,876,217 $ 2,174,802
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.3.1.900
Balance Sheets (Parentheticals) - $ / shares
Dec. 31, 2015
Jun. 30, 2015
Preferred stock par value (in Dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized 5,000,000 5,000,000
Preferred stock, shares issued 2,000,000 2,000,000
Preferred stock, shares outstanding 2,000,000 2,000,000
Common stock par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 75,000,000 75,000,000
Common stock, shares issued 41,800,287 41,441,620
Common stock, shares outstanding 41,800,287 41,441,620
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.3.1.900
Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2015
Dec. 31, 2014
NET SALES $ 914,888 $ 1,349,336 $ 1,928,821 $ 2,381,060
COST OF GOODS SOLD 696,671 1,035,209 1,463,447 1,836,865
GROSS PROFIT 218,217 314,127 465,374 544,195
EXPENSES        
Research and development 55,962 57,646 109,567 97,490
Sales and marketing 68,595 167,346 166,259 286,205
General and administrative 269,800 217,759 494,640 448,295
Total Expenses 394,357 442,751 770,466 831,990
LOSS FROM OPERATIONS (176,140) (128,624) (305,092) (287,795)
OTHER INCOME/(EXPENSE)        
Interest expense (935) 0 (1,534) 0
Interest income 36 159 109 366
Total Other Income/(Expense) (899) 159 (1,425) 366
NET LOSS (177,039) (128,465) (306,517) (287,429)
Preferred Stock Dividend (25,000) (25,000) (50,000) (50,000)
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS $ (202,039) $ (153,465) $ (356,517) $ (337,429)
BASIC AND DILUTED LOSS PER SHARE (in Dollars per share) $ 0.00 $ 0.00 $ (0.01) $ (0.01)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING (in Shares) 41,731,809 41,441,620 41,681,483 41,441,620
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.3.1.900
Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Dec. 31, 2015
Dec. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (306,517) $ (287,429)
Adjustments to reconcile net loss to net cash used by operating activities:    
Depreciation and amortization expense 81,028 90,627
Change in allowance for bad debt expense (recovery) (289) (8,066)
Stock paid for services 0 5,147
Stock based compensation related to consultant, employee and director options 41,795 13,571
Changes in operating assets and liabilities:    
Accounts receivable 7,764 (110,633)
Inventory and inventory reserve 5,899 53,115
Prepaid and other current assets (68,268) (29,015)
Accounts payable and accrued expenses (7,656) 430
Net Cash Used by Operating Activities (246,244) (272,253)
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchase of property and equipment 0 (31,721)
Net Cash Used by Investing Activities 0 (31,721)
CASH FLOWS FROM FINANCING ACTIVITIES    
Payments on lease liability (2,018) 0
Payments on notes payable (1,167) (1,460)
Preferred stock issuance costs 0 (188)
Preferred stock dividends (50,000) (50,000)
Net Cash (Used) by Financing Activities (53,185) (51,648)
NET DECREASE IN CASH (299,429) (355,622)
CASH AT BEGINNING OF PERIOD 455,717 728,585
CASH AT END OF PERIOD 156,288 372,963
SUPPLEMENTAL SCHEDULE OF CASH FLOW ACTIVITIES    
Interest paid 1,534 0
Income taxes paid 0 0
NON-CASH INVESTING AND FINANCING ACTIVITIES    
Capitalized lease 19,337 0
Reclassification of accounts receivable – related party to accounts receivable 6,312 0
Equipment purchase accrued for, not paid in cash $ 7,641 $ 0
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900
NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION
 6 Months Ended
Dec. 31, 2015
Disclosure Text Block [Abstract]  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION

The accompanying unaudited condensed financial statements have been prepared by us pursuant to the rules and regulations of the Securities and Exchange Commission.  Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted in accordance with such rules and regulations.  The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements.  We believe the disclosures and information presented are adequate to make the information not misleading.  These interim condensed financial statements should be read in conjunction with our most recent audited financial statements and notes thereto included in our June 30, 2015 Annual Report on Form 10-K.  Operating results for the six months ended December 31, 2015 are not necessarily indicative of the results that may be expected for the current fiscal year ending June 30, 2016.

XML 19 R7.htm IDEA: XBRL DOCUMENT v3.3.1.900
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 6 Months Ended
Dec. 31, 2015
Accounting Policies [Abstract]  
Significant Accounting Policies [Text Block]
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Significant accounting policies disclosed therein have not changed since our audited financial statements and notes thereto included in our June 30, 2015 Annual Report on Form 10-K, except as noted below.

Reclassifications

Certain reclassifications, which have no effect on net loss, have been made in the prior period financial statements, specifically the recognition of the preferred share dividend as a non-cash transaction at December 31, 2014.

Trade Receivables

We generally charge-off trade receivables that are more than 120 days outstanding as bad-debt expense, unless management believes the amount to be collectable. The charge-off amounts are included in general and administrative expenses. As of December 31, 2015 and 2014, the reserve for uncollectible accounts was $-0- and $7,296, respectively.

Stock Based-Compensation Expense

We account for stock-based compensation under the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 718, Compensation – Stock Compensation (ASC 718).  Our financial statements as of and for the quarters ended December 31, 2015 and 2014 reflect the impact of ASC 718.  Stock-based compensation expense related to director, employee or consultant options recognized under ASC 718 for the six months ended December 31, 2015 and 2014 was $41,795 and $13,571, respectively.

ASC 718 requires companies to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model.  The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in our Statement of Operations.  Stock-based compensation expense recognized in our Statements of Operations for the six months ended December 31, 2015 and 2014 assumes all awards will vest; therefore no reduction has been made for estimated forfeitures.  We have awarded some options with a performance requirement and no amounts will be recorded until the requirement is met.

Basic and Fully Diluted Net Loss Per Share

Basic and Fully Diluted net loss per share is computed using the weighted-average number of common shares outstanding during the period.

Our outstanding stock options and warrants and shares issuable upon conversion of outstanding convertible notes have been excluded from the basic and fully diluted net loss per share calculation.  We excluded 3,700,000 and 2,834,000 common stock equivalents for the six months ended December 31, 2015 and 2014, respectively, because they are anti-dilutive.

Recent Accounting Pronouncements

Recently Adopted and Recently Issued Accounting Guidance

Issued

In January 2015, the FASB issued ASU 2015-01, “Income Statement – Extraordinary and Unusual Items (Subtopic 225-20),” which eliminates the concept of extraordinary items. The new guidance is effective for fiscal years and interim periods within those years beginning after December 15, 2015. The new guidance is to be applied prospectively but may also be applied retrospectively to all prior periods presented in the financial statements. Early adoption is permitted provided that the guidance is applied from the beginning of the fiscal year of adoption. We expect to adopt the provisions of this new guidance on July 1, 2016. We do not expect the adoption of the new provisions to have a material impact on our financial condition or results of operations.

In November 2015, the FASB issued ASU No. 2015-17, “Balance Sheet Classification of Deferred Taxes,” requiring all deferred tax assets and liabilities, and any related valuation allowance, to be classified as noncurrent on the balance sheet. The classification change for all deferred taxes as noncurrent simplifies entities’ processes as it eliminates the need to separately identify the net current and net noncurrent deferred tax asset or liability in each jurisdiction and allocate valuation allowances. We do not expect the adoption of the new provisions to have a material impact on our financial condition or results of operations.

In July 2015, the FASB issued ASU No. 2015-11, “Simplifying the Measurement of Inventory”. Under ASU 2015-11, inventory will be measured at the “lower of cost and net realizable value” and options that currently exist for “market value” will be eliminated. The standard defines net realizable value as the “estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.” No other changes were made to the current guidance on inventory measurement. ASU 2015-11 is effective for interim and annual periods beginning after December 15, 2016. Early application is permitted and should be applied prospectively. The Company is currently evaluating the impact the adoption of ASU 2015-11 will have on its financial statements.

Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the SEC, did not, or are not believed by management to, have a material impact on the Company's present or future financial position, results of operations or cash flows.

Related Party Transactions

Amerityre’s immediate past Chairman of the Board, Timothy L. Ryan, is also the principal owner of Rhino Rubber LLC, a manufacturing and distribution company for solid industrial tires and wheels.  As of December 31, 2015, Mr. Ryan is no longer a director of the Company and all receivables outstanding to Rhino Rubber LLC have been reflected as trade accounts receivable.

We currently distribute directly from our manufacturing facility in Boulder City, Nevada only.  In the past we also distributed from an independent, contracted warehouse in Ravenna, Ohio.  This contract distribution point was unable to support customer requirements, became ineffective and stopped operations in the second quarter of 2014.  In order to keep commitments to customers and keep revenue growth positive, distribution and other related services were transferred to Rhino Rubber in Akron, Ohio.  The Company paid $600 for monthly warehousing fees inclusive of freight, shipping and labor for mounting services through October 31, 2015.  Effective October 31, 2015 we closed the Akron, Ohio distribution point and customers are serviced on a direct basis.

XML 20 R8.htm IDEA: XBRL DOCUMENT v3.3.1.900
NOTE 3 - INVENTORY
 6 Months Ended
Dec. 31, 2015
Inventory Disclosure [Abstract]  
Inventory Disclosure [Text Block]
NOTE 3 - INVENTORY

Inventory is stated at the lower of cost (computed on a first-in, first-out basis) or net realizable value.  The inventory consists primarily of chemicals, finished goods produced in our plant and products purchased for resale.

   
December 31, 2015
   
June 30, 2015
 
   
(Unaudited)
       
Raw Materials
 
$
272,689
   
$
302,910
 
Finished Goods
   
695,243
     
655,714
 
Inventory reserve
   
(126,142
)
   
(110,935
)
Inventory - net
 
$
841,790
     
847,689
 

Our inventory reserve reflects items that were deemed to be slow moving or obsolete based on an analysis of all inventories on hand.

The Company critically reviews all slow moving inventory to determine if defective or obsolete.  If not defective or obsolete, but slow moving, we present these items as non-current inventory, although all inventory is ready and available for sale at any moment.  

XML 21 R9.htm IDEA: XBRL DOCUMENT v3.3.1.900
NOTE 4 - CAPITAL LEASE
 6 Months Ended
Dec. 31, 2015
Disclosure Text Block Supplement [Abstract]  
Debt and Capital Leases Disclosures [Text Block]
NOTE 4 - CAPITAL LEASE

In July 2015 the Company entered into a capital lease for research and development equipment for $19,337.

The following is a schedule by years of future minimum lease payments under capital leases together with present value of the net minimum lease payments as of December 31, 2015:

2016
  $ 4,349  
2017
    8,697  
2018
    8,697  
2019
    725  
2020
    -  
Total minimum lease payments
    22,468  
Less:  executory costs
    -  
Net minimum lease payments
    22,468  
Less:  amount representing interest
    5,149  
Present value of net minimum payments
  $ 17,319  

XML 22 R10.htm IDEA: XBRL DOCUMENT v3.3.1.900
NOTE 5 - STOCK TRANSACTIONS
 6 Months Ended
Dec. 31, 2015
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Note Disclosure [Text Block]
NOTE 5 - STOCK TRANSACTIONS

In July 2015 the Board of Directors granted the following stock bonus awards:

·  
To all non-officer employees of Amerityre on record as of July 22, 2015, a one-time stock bonus award of 5,000 shares of the Company’s restricted common stock per employee, valued at $0.015 a share (fair value on the date of grant with a 50% discount pursuant to U.S. Internal Revenue Service, revenue Ruling 77-287).  As of July 22, 2015 there were 16 non-officer employees at Amerityre resulting in 80,000 shares, which were issued in July 2015.

·  
To the officers of Amerityre, 600,000 shares were granted on July 20, 2015 (valued at $0.03) with 75% of the grant allocated to the CEO and 25% of the grant allocated to the CFO.  The shares of stock vest ratably each quarter end during fiscal year 2016 and are payable immediately after the vesting date.  For the six months ended December 31, 2015 the Company recognized $9,000 of compensation expense for these grants; $4,500 of which is a stock payable.

XML 23 R11.htm IDEA: XBRL DOCUMENT v3.3.1.900
NOTE 6 - STOCK OPTIONS AND WARRANTS
 6 Months Ended
Dec. 31, 2015
Disclosure Text Block Supplement [Abstract]  
Shareholders' Equity and Share-based Payments [Text Block]
NOTE 6 - STOCK OPTIONS AND WARRANTS

General Option Information

On July 6, 2011, the Board of Directors cancelled the “2004 Non-Employee Directors’ Stock Incentive Plan” and approved the "Directors’ 2011 Stock Option and Award Plan”.   Under the 2011 Plan, a total of 3,300,000 shares are authorized for issuance.

The Company also maintained the 2005 Stock Option and Award Plan, which was previously approved by shareholders, for the purpose of granting option awards to its employees and consultants.   This plan had a 10 year life and expired July 2015.

On August 10, 2015, the Board of Directors cancelled the “Directors’ 2011 Stock Option and Award Plan” as all options under this plan had been granted and adopted the “2015 Omnibus Stock Option and Award Plan” which contains provisions for up to 3,000,000 stock options to be granted to employees, consultants and directors.  The 2015 Omnibus Stock Option and Award Plan did not obtain the necessary shareholder approval in the Company’s annual proxy process, resulting in certain U.S. Internal Revenue Service provisions to be ineffective.

Option issuances and vesting during the six month period ending December 31, 2015

On December 1, 2014, 480,000 options were granted to the Company’s Chief Executive Officer (then our Chief Operating Officer) as part of his employment offer.  The options have a strike price of $0.10, vest December 1, 2015 and expire December 1, 2020.  Year to date expense related to these options is $7,746 as of December 31, 2015. 

On January 21, 2015, 50,000 options were granted to the Company’s Chief Financial Officer as part of her employment offer.  The options have a strike price of $0.10, vest ratably January 21, 2015 to December 1, 2015 and expire December 1, 2018.  Year to date expense related to these options is $840 as of December 31, 2015.

In the October 2015 Board meeting, the Board granted all non-executive Board members 100,000 options, with the audit committee chair receiving an additional 50,000 options, for Board services rendered for the fiscal year ended June 30, 2015.  The options have a strike price of $0.10, vest at the end of the Board term on December 3, 2015 and expire December 3, 2017.  Expense related to these options is $21,950 as of December 31, 2015.

On December 1, 2015, 480,000 options were granted to the Company’s Chief Executive Officer (then our Chief Operating Officer) as part of his employment offer.  The options have a strike price of $0.10, vest December 1, 2016 and expire December 1, 2020.  Year to date expense related to these options is $1,060 as of December 31, 2015. 

As of December 31, 2015, there was $11,655 of unrecognized stock-based compensation expense related to stock options that will be recognized over the vest period of the underlying option.

We estimated the fair value of the stock options above at the grant date based on the following weighted average assumptions:

Risk free interest rate
    1.155
% 
Expected life
    2.0 – 4.5
 years 
Expected volatility
    167.37 – 113.50
% 
Dividend yield
    0.00
% 

A summary of the status of our outstanding stock options as of December 31, 2015 and June 30, 2015 and changes during the periods then ended is presented below:

   
December 31, 2015
   
June 30, 2015
 
         
Weight Average
   
Intrinsic
         
Weight Average
   
Intrinsic
 
   
Shares
   
Exercise Price
   
Value
   
Shares
   
Exercise Price
   
Value
 
Outstanding beginning of period
    2,270,000     $ 0.14             1,754,000     $ 0.17        
Granted
    1,030,000     $ 0.10             670,000     $ 0.10        
Expired/Cancelled
    -     $ 0.00             (154,000 )   $ (0.29 )      
Exercised
    -     $ 0.00             -     $ 0.00        
Outstanding end of period
    3,300,000     $ 0.13     $ 132,000       2,270,000     $ 0.14     $ 45,400  
Exercisable
    2,820,000     $ 0.13     $ 112,800       1,752,500     $ 0.16     $ 35,050  

The intrinsic value of outstanding and exercisable shares is based on the closing price of the Company’s common stock of $0.04 per share on December 31, 2015 ($0.02 per share on June 30, 2015), the last trading day of the quarter.

The following table summarizes the range of outstanding and exercisable options as of December 31, 2015:

     
Outstanding
   
Exercisable
 
 
Range of
Exercise Prices
   
Number Outstanding
at
December 31, 2015
   
Weighted
Average
Remaining
Contractual Life
   
 
Weighted
Average
Exercise Price
   
 
Number
Exercisable at
December 31, 2015
   
Weighted
Average Remaining
Contractual Life
 
$
0.08
     
150,000
     
5.92
   
$
0.08
     
150,000
     
5.92
 
$
0.10
     
1,700,000
     
3.96
   
$
0.10
     
1,220,000
     
3.96
 
$
0.17
     
650,000
     
3.92
   
$
0.17
     
650,000
     
3.92
 
$
0.17
     
400,000
     
4.92
   
$
0.17
     
400,000
     
4.92
 
$
0.17
     
400,000
     
5.92
   
$
0.17
     
400,000
     
5.92
 
         
3,300,000
                     
2,820,000
         

General Warrant Information

In September 2013, the Company obtained an extension on the remaining $100,000 secured convertible promissory note that was issued in the private placement that closed in September 2010.  This note was paid off as of June 30, 2015.   In exchange for the extension, the note holder received 500,000 common stock warrants and $6,500 in accrued interest and fees.  The common stock warrants expire three years from the date of issuance, are exercisable at $0.13 per share, and vest on the next date the value of Amerityre common stock reaches $0.25 per share.  As of December 31, 2015 the warrants have not vested.

XML 24 R12.htm IDEA: XBRL DOCUMENT v3.3.1.900
NOTE 7 - LIQUIDITY
 6 Months Ended
Dec. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Substantial Doubt about Going Concern [Text Block]
NOTE 7 - LIQUIDITY

Over the past year, we have been working on various proposals to secure short-term loans as well as long-term bank financing and equity based investments. The Company currently does not have an existing credit facility. Over the past year, we have worked with our vendors to obtain extended credit terms and increase credit lines where needed. Additionally, we continue to focus on adherence to established collection policies and proactive communication with repeat customers, including adjusting credit limits to allow for increased sales volume where warranted.

We are intent on focusing on the sale and distribution of profitable product lines. Management continues to look for further financing facilities at affordable terms that will allow the Company to maintain sufficient raw material and finished goods inventory to capitalize on sales growth opportunities. No additional capital expenditures are anticipated over the next twelve months unless they support sales development and product improvement.  We continue to work to reduce our overall costs wherever possible.

To help address our cash resources which at times may be limited, we are in discussions with various third parties about potential opportunities to license our technology which we believe will bring in additional cash flows without diluting our common stock or requiring the addition of debt. We are in discussions with banks and other lenders regarding establishing a line of credit for short term cash needs, however at this time we have not succeeded in establishing such a line of credit.  Lastly, we have entered into a short term receivable factoring agreement with a third party to sell our receivable invoices.  This agreement enables us to sell individual customer invoices for faster cash flow to the Company as we deem needed.

As of December 31, 2015, the Company has approximately 7,064,000 shares authorized and available for issuance. Although we are reluctant to raise money through stock sales at what we believe are dilutive share prices, these authorized but unissued and unreserved shares of our common stock can be utilized if necessary to fund the expansion of our manufacturing operations or to obtain additional working capital.

The Company has also instituted initiatives to incentivize sales of slower moving inventory through promotional pricing. These programs will continue to be utilized in the upcoming quarters to monetize inventory and improve our cash flow.

In assessing our liquidity, management reviews and analyzes our current cash, accounts receivable, accounts payable, capital expenditure commitments and other obligations.  In connection with the preparation of our financial statements for the period ended December 31, 2015, we have analyzed our cash needs for the next twelve months. We have concluded that our available cash and accounts receivables are sufficient to meet our current minimum working capital, capital expenditure and other cash requirements for this period.

XML 25 R13.htm IDEA: XBRL DOCUMENT v3.3.1.900
NOTE 8 - SUBSEQUENT EVENTS
 6 Months Ended
Dec. 31, 2015
Subsequent Events [Abstract]  
Subsequent Events [Text Block]
NOTE 8 - SUBSEQUENT EVENTS

On January 19, 2016, the Board granted all non-executive Board members 100,000 options, with the audit committee chair receiving an additional 50,000 options, for Board services rendered for the fiscal year ended June 30, 2016.  The options have a strike price of $0.10, vest at the end of the Board term in December 2016 and expire December 2019.  

On January 19, 2016, 50,000 options were granted to the Company’s Chief Financial Officer as part of renewal of her employment agreement.  The options have a strike price of $0.10, vest ratably January 21, 2016 to December 1, 2016 and expire December 1, 2019.  In addition to the option renewal $550 a month in health insurance reimbursement was included in the renewal.  All other terms remain the same.

In January 2016, 150,000 shares that had vested at December 31, 2015 for the CEO and CFO were issued.

XML 26 R14.htm IDEA: XBRL DOCUMENT v3.3.1.900
Accounting Policies, by Policy (Policies)
 6 Months Ended
Dec. 31, 2015
Accounting Policies [Abstract]  
Reclassification, Policy [Policy Text Block]
Reclassifications

Certain reclassifications, which have no effect on net loss, have been made in the prior period financial statements, specifically the recognition of the preferred share dividend as a non-cash transaction at December 31, 2014.
Trade and Other Accounts Receivable, Policy [Policy Text Block]
Trade Receivables

We generally charge-off trade receivables that are more than 120 days outstanding as bad-debt expense, unless management believes the amount to be collectable. The charge-off amounts are included in general and administrative expenses. As of December 31, 2015 and 2014, the reserve for uncollectible accounts was $-0- and $7,296, respectively.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]
Stock Based-Compensation Expense

We account for stock-based compensation under the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 718, Compensation – Stock Compensation (ASC 718).  Our financial statements as of and for the quarters ended December 31, 2015 and 2014 reflect the impact of ASC 718.  Stock-based compensation expense related to director, employee or consultant options recognized under ASC 718 for the six months ended December 31, 2015 and 2014 was $41,795 and $13,571, respectively.

ASC 718 requires companies to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model.  The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in our Statement of Operations.  Stock-based compensation expense recognized in our Statements of Operations for the six months ended December 31, 2015 and 2014 assumes all awards will vest; therefore no reduction has been made for estimated forfeitures.  We have awarded some options with a performance requirement and no amounts will be recorded until the requirement is met.
Earnings Per Share, Policy [Policy Text Block]
Basic and Fully Diluted Net Loss Per Share

Basic and Fully Diluted net loss per share is computed using the weighted-average number of common shares outstanding during the period.

Our outstanding stock options and warrants and shares issuable upon conversion of outstanding convertible notes have been excluded from the basic and fully diluted net loss per share calculation.  We excluded 3,700,000 and 2,834,000 common stock equivalents for the six months ended December 31, 2015 and 2014, respectively, because they are anti-dilutive.
New Accounting Pronouncements, Policy [Policy Text Block]
Recent Accounting Pronouncements

Recently Adopted and Recently Issued Accounting Guidance

Issued

In January 2015, the FASB issued ASU 2015-01, “Income Statement – Extraordinary and Unusual Items (Subtopic 225-20),” which eliminates the concept of extraordinary items. The new guidance is effective for fiscal years and interim periods within those years beginning after December 15, 2015. The new guidance is to be applied prospectively but may also be applied retrospectively to all prior periods presented in the financial statements. Early adoption is permitted provided that the guidance is applied from the beginning of the fiscal year of adoption. We expect to adopt the provisions of this new guidance on July 1, 2016. We do not expect the adoption of the new provisions to have a material impact on our financial condition or results of operations.

In November 2015, the FASB issued ASU No. 2015-17, “Balance Sheet Classification of Deferred Taxes,” requiring all deferred tax assets and liabilities, and any related valuation allowance, to be classified as noncurrent on the balance sheet. The classification change for all deferred taxes as noncurrent simplifies entities’ processes as it eliminates the need to separately identify the net current and net noncurrent deferred tax asset or liability in each jurisdiction and allocate valuation allowances. We do not expect the adoption of the new provisions to have a material impact on our financial condition or results of operations.

In July 2015, the FASB issued ASU No. 2015-11, “Simplifying the Measurement of Inventory”. Under ASU 2015-11, inventory will be measured at the “lower of cost and net realizable value” and options that currently exist for “market value” will be eliminated. The standard defines net realizable value as the “estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.” No other changes were made to the current guidance on inventory measurement. ASU 2015-11 is effective for interim and annual periods beginning after December 15, 2016. Early application is permitted and should be applied prospectively. The Company is currently evaluating the impact the adoption of ASU 2015-11 will have on its financial statements.

Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the SEC, did not, or are not believed by management to, have a material impact on the Company's present or future financial position, results of operations or cash flows.
Related Party Transactions Policy [Policy Text Block]
Related Party Transactions

Amerityre’s immediate past Chairman of the Board, Timothy L. Ryan, is also the principal owner of Rhino Rubber LLC, a manufacturing and distribution company for solid industrial tires and wheels.  As of December 31, 2015, Mr. Ryan is no longer a director of the Company and all receivables outstanding to Rhino Rubber LLC have been reflected as trade accounts receivable.

We currently distribute directly from our manufacturing facility in Boulder City, Nevada only.  In the past we also distributed from an independent, contracted warehouse in Ravenna, Ohio.  This contract distribution point was unable to support customer requirements, became ineffective and stopped operations in the second quarter of 2014.  In order to keep commitments to customers and keep revenue growth positive, distribution and other related services were transferred to Rhino Rubber in Akron, Ohio.  The Company paid $600 for monthly warehousing fees inclusive of freight, shipping and labor for mounting services through October 31, 2015.  Effective October 31, 2015 we closed the Akron, Ohio distribution point and customers are serviced on a direct basis.
XML 27 R15.htm IDEA: XBRL DOCUMENT v3.3.1.900
NOTE 3 - INVENTORY (Tables)
 6 Months Ended
Dec. 31, 2015
Inventory Disclosure [Abstract]  
Schedule of Inventory [Table Text Block] Inventory is stated at the lower of cost (computed on a first-in, first-out basis) or net realizable value. The inventory consists primarily of chemicals, finished goods produced in our plant and products purchased for resale.

   
December 31, 2015
   
June 30, 2015
 
   
(Unaudited)
       
Raw Materials
 
$
272,689
   
$
302,910
 
Finished Goods
   
695,243
     
655,714
 
Inventory reserve
   
(126,142
)
   
(110,935
)
Inventory - net
 
$
841,790
     
847,689
 
XML 28 R16.htm IDEA: XBRL DOCUMENT v3.3.1.900
NOTE 4 - CAPITAL LEASE (Tables)
 6 Months Ended
Dec. 31, 2015
Disclosure Text Block Supplement [Abstract]  
Schedule of Capital Leased Assets [Table Text Block] The following is a schedule by years of future minimum lease payments under capital leases together with present value of the net minimum lease payments as of December 31, 2015:

2016
  $ 4,349  
2017
    8,697  
2018
    8,697  
2019
    725  
2020
    -  
Total minimum lease payments
    22,468  
Less:  executory costs
    -  
Net minimum lease payments
    22,468  
Less:  amount representing interest
    5,149  
Present value of net minimum payments
  $ 17,319  
XML 29 R17.htm IDEA: XBRL DOCUMENT v3.3.1.900
NOTE 6 - STOCK OPTIONS AND WARRANTS (Tables)
 6 Months Ended
Dec. 31, 2015
Disclosure Text Block Supplement [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] We estimated the fair value of the stock options above at the grant date based on the following weighted average assumptions:

Risk free interest rate
    1.155
% 
Expected life
    2.0 – 4.5
 years 
Expected volatility
    167.37 – 113.50
% 
Dividend yield
    0.00
% 
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] A summary of the status of our outstanding stock options as of December 31, 2015 and June 30, 2015 and changes during the periods then ended is presented below:

   
December 31, 2015
   
June 30, 2015
 
         
Weight Average
   
Intrinsic
         
Weight Average
   
Intrinsic
 
   
Shares
   
Exercise Price
   
Value
   
Shares
   
Exercise Price
   
Value
 
Outstanding beginning of period
    2,270,000     $ 0.14             1,754,000     $ 0.17        
Granted
    1,030,000     $ 0.10             670,000     $ 0.10        
Expired/Cancelled
    -     $ 0.00             (154,000 )   $ (0.29 )      
Exercised
    -     $ 0.00             -     $ 0.00        
Outstanding end of period
    3,300,000     $ 0.13     $ 132,000       2,270,000     $ 0.14     $ 45,400  
Exercisable
    2,820,000     $ 0.13     $ 112,800       1,752,500     $ 0.16     $ 35,050  
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block] The following table summarizes the range of outstanding and exercisable options as of December 31, 2015:

     
Outstanding
   
Exercisable
 
 
Range of
Exercise Prices
   
Number Outstanding
at
December 31, 2015
   
Weighted
Average
Remaining
Contractual Life
   
 
Weighted
Average
Exercise Price
   
 
Number
Exercisable at
December 31, 2015
   
Weighted
Average Remaining
Contractual Life
 
$
0.08
     
150,000
     
5.92
   
$
0.08
     
150,000
     
5.92
 
$
0.10
     
1,700,000
     
3.96
   
$
0.10
     
1,220,000
     
3.96
 
$
0.17
     
650,000
     
3.92
   
$
0.17
     
650,000
     
3.92
 
$
0.17
     
400,000
     
4.92
   
$
0.17
     
400,000
     
4.92
 
$
0.17
     
400,000
     
5.92
   
$
0.17
     
400,000
     
5.92
 
         
3,300,000
                     
2,820,000
         
XML 30 R18.htm IDEA: XBRL DOCUMENT v3.3.1.900
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
 6 Months Ended
Dec. 31, 2015
Dec. 31, 2014
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]    
Allowance for Doubtful Accounts Receivable $ 0 $ 7,296
Share-based Compensation $ 41,795 $ 13,571
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares) 3,700,000 2,834,000
Affiliated Entity [Member]    
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]    
Costs and Expenses, Related Party $ 600  
XML 31 R19.htm IDEA: XBRL DOCUMENT v3.3.1.900
NOTE 3 - INVENTORY (Details) - Schedule of Inventory - USD ($)
Dec. 31, 2015
Jun. 30, 2015
Schedule of Inventory [Abstract]    
Raw Materials $ 272,689 $ 302,910
Finished Goods 695,243 655,714
Inventory reserve (126,142) (110,935)
Inventory - net $ 841,790 $ 847,689
XML 32 R20.htm IDEA: XBRL DOCUMENT v3.3.1.900
NOTE 4 - CAPITAL LEASE (Details) - USD ($)
Dec. 31, 2015
Jul. 31, 2015
Disclosure Text Block Supplement [Abstract]    
Capital Leases, Future Minimum Payments Due $ 22,468 $ 19,337
XML 33 R21.htm IDEA: XBRL DOCUMENT v3.3.1.900
NOTE 4 - CAPITAL LEASE (Details) - Schedule of Capital Leased Assets - USD ($)
Dec. 31, 2015
Jul. 31, 2015
Schedule of Capital Leased Assets [Abstract]    
2016 $ 4,349  
2017 8,697  
2018 8,697  
2019 725  
2020 0  
Total minimum lease payments 22,468 $ 19,337
Less: executory costs 0  
Net minimum lease payments 22,468  
Less: amount representing interest 5,149  
Present value of net minimum payments $ 17,319  
XML 34 R22.htm IDEA: XBRL DOCUMENT v3.3.1.900
NOTE 5 - STOCK TRANSACTIONS (Details) - USD ($)
 6 Months Ended
Jul. 22, 2015
Jul. 20, 2015
Dec. 31, 2015
Dec. 31, 2014
NOTE 5 - STOCK TRANSACTIONS (Details) [Line Items]        
Stock Issued During Period, Shares, Share-based Compensation, Gross 80,000 600,000    
Shares Issued, Price Per Share $ 0.015 $ 0.03    
Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date 50.00%      
Share-based Compensation     $ 41,795 $ 13,571
Each Employee [Member]        
NOTE 5 - STOCK TRANSACTIONS (Details) [Line Items]        
Stock Issued During Period, Shares, Share-based Compensation, Gross 5,000      
Chief Executive Officer [Member]        
NOTE 5 - STOCK TRANSACTIONS (Details) [Line Items]        
Grant Allocation   75.00%    
Chief Financial Officer [Member]        
NOTE 5 - STOCK TRANSACTIONS (Details) [Line Items]        
Grant Allocation   25.00%    
CEO and CFO [Member]        
NOTE 5 - STOCK TRANSACTIONS (Details) [Line Items]        
Share-based Compensation     9,000  
Stock Payable     $ 4,500  
XML 35 R23.htm IDEA: XBRL DOCUMENT v3.3.1.900
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - USD ($)
 1 Months Ended 6 Months Ended 12 Months Ended
Dec. 01, 2015
Jan. 21, 2015
Dec. 01, 2014
Jul. 06, 2011
Oct. 31, 2015
Sep. 30, 2013
Dec. 31, 2015
Jun. 30, 2015
Aug. 10, 2015
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]                  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross             1,030,000 670,000  
Allocated Share-based Compensation Expense             $ 1,060    
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options             $ 11,655    
Share Price             $ 0.04 $ 0.02  
Directors' 2011 Stock Option and Award Plan [Member]                  
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]                  
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized       3,300,000          
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period       10 years          
2015 Omnibus Stock Option and Award Plan [Member]                  
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]                  
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized                 3,000,000
Convertible Debt [Member]                  
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]                  
Share Price           $ 0.25      
Convertible Notes Payable, Current           $ 100,000      
Class of Warrant or Rights, Granted           500,000      
Debt Issuance Cost           $ 6,500      
Warrants, Term of Warrants           3 years      
Class of Warrant or Right, Exercise Price of Warrants or Rights           $ 0.13      
Chief Executive Officer [Member]                  
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]                  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 480,000   480,000            
Share-Based Compensation Arrangement by Share-Based Payment Award, Option Exercise Price $ 0.10   $ 0.10            
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Date Dec. 01, 2016   Dec. 01, 2015            
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date Dec. 01, 2020   Dec. 01, 2020            
Allocated Share-based Compensation Expense             $ 7,746    
Chief Financial Officer [Member]                  
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]                  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross   50,000              
Share-Based Compensation Arrangement by Share-Based Payment Award, Option Exercise Price   $ 0.10              
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date   Dec. 01, 2018              
Allocated Share-based Compensation Expense             840    
Board member [Member]                  
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]                  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross         100,000        
Share-Based Compensation Arrangement by Share-Based Payment Award, Option Exercise Price         $ 0.10        
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Date         Dec. 03, 2015        
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date         Dec. 03, 2017        
Allocated Share-based Compensation Expense             $ 21,950    
Audit Committee Chair [Member]                  
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]                  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross         50,000        
Minimum [Member] | Chief Financial Officer [Member]                  
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]                  
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Date   Jan. 21, 2015              
Maximum [Member] | Chief Financial Officer [Member]                  
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]                  
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Date   Dec. 01, 2015              
XML 36 R24.htm IDEA: XBRL DOCUMENT v3.3.1.900
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Valuation Assumptions
 6 Months Ended
Dec. 31, 2015
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Valuation Assumptions [Line Items]  
Risk free interest rate 1.155%
Dividend yield 0.00%
Minimum [Member]  
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Valuation Assumptions [Line Items]  
Expected life 2 years
Expected volatility 167.37%
Maximum [Member]  
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Valuation Assumptions [Line Items]  
Expected life 4 years 6 months
Expected volatility 113.50%
XML 37 R25.htm IDEA: XBRL DOCUMENT v3.3.1.900
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Stock Options, Activity - USD ($)
 6 Months Ended 12 Months Ended
Dec. 31, 2015
Jun. 30, 2015
Schedule of Share-based Compensation, Stock Options, Activity [Abstract]    
Outstanding beginning of period 2,270,000 1,754,000
Outstanding beginning of period $ 0.14 $ 0.17
Granted 1,030,000 670,000
Granted $ 0.10 $ 0.10
Expired/Cancelled 0 (154,000)
Expired/Cancelled $ (0.00) $ (0.29)
Exercised 0 0
Exercised $ 0.00 $ 0.00
Exercised $ 0 $ 0
Outstanding end of period 3,300,000 2,270,000
Outstanding end of period $ 0.13 $ 0.14
Outstanding end of period $ 132,000 $ 45,400
Exercisable 2,820,000 1,752,500
Exercisable $ 0.13 $ 0.16
Exercisable $ 112,800 $ 35,050
XML 38 R26.htm IDEA: XBRL DOCUMENT v3.3.1.900
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range - $ / shares
 6 Months Ended
Dec. 31, 2015
Jun. 30, 2015
Jun. 30, 2014
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]      
Number of Options Outstanding 3,300,000 2,270,000 1,754,000
Weighted Average Exercise Price of Outstanding Options (in Dollars per share) $ 0.13 $ 0.14 $ 0.17
Number of Exercisable Options 2,820,000 1,752,500  
Options at $0.08 [Member]      
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]      
Exercise Price of Options (in Dollars per share) $ 0.08    
Number of Options Outstanding 150,000    
Weighted Average Remaining Contractual Life of Outstanding Options 5 years 335 days    
Weighted Average Exercise Price of Outstanding Options (in Dollars per share) $ 0.08    
Number of Exercisable Options 150,000    
Weighted Average Remaining Contractual Life of Exercisable Options 5 years 335 days    
Options at $0.10 [Member]      
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]      
Exercise Price of Options (in Dollars per share) $ 0.10    
Number of Options Outstanding 1,700,000    
Weighted Average Remaining Contractual Life of Outstanding Options 3 years 350 days    
Weighted Average Exercise Price of Outstanding Options (in Dollars per share) $ 0.10    
Number of Exercisable Options 1,220,000    
Weighted Average Remaining Contractual Life of Exercisable Options 3 years 350 days    
Options at $0.17 [Member]      
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]      
Exercise Price of Options (in Dollars per share) $ 0.17    
Number of Options Outstanding 650,000    
Weighted Average Remaining Contractual Life of Outstanding Options 3 years 335 days    
Weighted Average Exercise Price of Outstanding Options (in Dollars per share) $ 0.17    
Number of Exercisable Options 650,000    
Weighted Average Remaining Contractual Life of Exercisable Options 3 years 335 days    
Options at $0.17 #2 [Member]      
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]      
Exercise Price of Options (in Dollars per share) $ 0.17    
Number of Options Outstanding 400,000    
Weighted Average Remaining Contractual Life of Outstanding Options 4 years 335 days    
Weighted Average Exercise Price of Outstanding Options (in Dollars per share) $ 0.17    
Number of Exercisable Options 400,000    
Weighted Average Remaining Contractual Life of Exercisable Options 4 years 335 days    
Options at $0.17 #3 [Member]      
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]      
Exercise Price of Options (in Dollars per share) $ 0.17    
Number of Options Outstanding 400,000    
Weighted Average Remaining Contractual Life of Outstanding Options 5 years 335 days    
Weighted Average Exercise Price of Outstanding Options (in Dollars per share) $ 0.17    
Number of Exercisable Options 400,000    
Weighted Average Remaining Contractual Life of Exercisable Options 5 years 335 days    
XML 39 R27.htm IDEA: XBRL DOCUMENT v3.3.1.900
NOTE 7 - LIQUIDITY (Details)
 6 Months Ended
Dec. 31, 2015
shares
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Shares Available for Issuance 7,064,000
XML 40 R28.htm IDEA: XBRL DOCUMENT v3.3.1.900
NOTE 8 - SUBSEQUENT EVENTS (Details) - USD ($)
 1 Months Ended 6 Months Ended 12 Months Ended
Jan. 19, 2016
Jan. 21, 2015
Jan. 31, 2016
Oct. 31, 2015
Dec. 31, 2015
Jun. 30, 2015
NOTE 8 - SUBSEQUENT EVENTS (Details) [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross         1,030,000 670,000
Board member [Member]            
NOTE 8 - SUBSEQUENT EVENTS (Details) [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross       100,000    
Share-Based Compensation Arrangement by Share-Based Payment Award, Option Exercise Price (in Dollars per share)       $ 0.10    
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date       Dec. 03, 2017    
Board member [Member] | Subsequent Event [Member]            
NOTE 8 - SUBSEQUENT EVENTS (Details) [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 100,000          
Share-Based Compensation Arrangement by Share-Based Payment Award, Option Exercise Price (in Dollars per share) $ 0.10          
Board of Directors Chairman [Member] | Subsequent Event [Member]            
NOTE 8 - SUBSEQUENT EVENTS (Details) [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 50,000          
Chief Financial Officer [Member]            
NOTE 8 - SUBSEQUENT EVENTS (Details) [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross   50,000        
Share-Based Compensation Arrangement by Share-Based Payment Award, Option Exercise Price (in Dollars per share)   $ 0.10        
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date   Dec. 01, 2018        
Chief Financial Officer [Member] | Subsequent Event [Member]            
NOTE 8 - SUBSEQUENT EVENTS (Details) [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 50,000          
Share-Based Compensation Arrangement by Share-Based Payment Award, Option Exercise Price (in Dollars per share) $ 0.10          
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights vest ratably January 21, 2016 to December 1, 2016          
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date Dec. 01, 2019          
Chief Financial Officer [Member] | Subsequent Event [Member] | Monthly Health Insurance Reimbursement [Member]            
NOTE 8 - SUBSEQUENT EVENTS (Details) [Line Items]            
Other Commitment (in Dollars) $ 550          
CEO and CFO [Member] | Subsequent Event [Member]            
NOTE 8 - SUBSEQUENT EVENTS (Details) [Line Items]            
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures     150,000      
EXCEL 41 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 43 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 45 FilingSummary.xml IDEA: XBRL DOCUMENT 3.3.1.900 html 59 169 1 false 20 0 false 4 false false R1.htm 000 - Disclosure - Document And Entity Information Sheet http://www.amerityre.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Balance Sheets Sheet http://www.amerityre.com/role/ConsolidatedBalanceSheet Balance Sheets Statements 2 false false R3.htm 002 - Statement - Balance Sheets (Parentheticals) Sheet http://www.amerityre.com/role/ConsolidatedBalanceSheet_Parentheticals Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Statements of Operations (Unaudited) Sheet http://www.amerityre.com/role/ConsolidatedIncomeStatement Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Statements of Cash Flows (Unaudited) Sheet http://www.amerityre.com/role/ConsolidatedCashFlow Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 005 - Disclosure - NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION Sheet http://www.amerityre.com/role/NOTE1BASISOFFINANCIALSTATEMENTPRESENTATION NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION Notes 6 false false R7.htm 006 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.amerityre.com/role/NOTE2SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 7 false false R8.htm 007 - Disclosure - NOTE 3 - INVENTORY Sheet http://www.amerityre.com/role/NOTE3INVENTORY NOTE 3 - INVENTORY Notes 8 false false R9.htm 008 - Disclosure - NOTE 4 - CAPITAL LEASE Sheet http://www.amerityre.com/role/NOTE4CAPITALLEASE NOTE 4 - CAPITAL LEASE Notes 9 false false R10.htm 009 - Disclosure - NOTE 5 - STOCK TRANSACTIONS Sheet http://www.amerityre.com/role/NOTE5STOCKTRANSACTIONS NOTE 5 - STOCK TRANSACTIONS Notes 10 false false R11.htm 010 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS Sheet http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTS NOTE 6 - STOCK OPTIONS AND WARRANTS Notes 11 false false R12.htm 011 - Disclosure - NOTE 7 - LIQUIDITY Sheet http://www.amerityre.com/role/NOTE7LIQUIDITY NOTE 7 - LIQUIDITY Notes 12 false false R13.htm 012 - Disclosure - NOTE 8 - SUBSEQUENT EVENTS Sheet http://www.amerityre.com/role/NOTE8SUBSEQUENTEVENTS NOTE 8 - SUBSEQUENT EVENTS Notes 13 false false R14.htm 013 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://www.amerityre.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies 14 false false R15.htm 014 - Disclosure - NOTE 3 - INVENTORY (Tables) Sheet http://www.amerityre.com/role/NOTE3INVENTORYTables NOTE 3 - INVENTORY (Tables) Tables http://www.amerityre.com/role/NOTE3INVENTORY 15 false false R16.htm 015 - Disclosure - NOTE 4 - CAPITAL LEASE (Tables) Sheet http://www.amerityre.com/role/NOTE4CAPITALLEASETables NOTE 4 - CAPITAL LEASE (Tables) Tables http://www.amerityre.com/role/NOTE4CAPITALLEASE 16 false false R17.htm 016 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Tables) Sheet http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSTables NOTE 6 - STOCK OPTIONS AND WARRANTS (Tables) Tables http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTS 17 false false R18.htm 017 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://www.amerityre.com/role/NOTE2SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://www.amerityre.com/role/NOTE2SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES 18 false false R19.htm 018 - Disclosure - NOTE 3 - INVENTORY (Details) - Schedule of Inventory Sheet http://www.amerityre.com/role/ScheduleofInventoryTable NOTE 3 - INVENTORY (Details) - Schedule of Inventory Details http://www.amerityre.com/role/NOTE3INVENTORYTables 19 false false R20.htm 019 - Disclosure - NOTE 4 - CAPITAL LEASE (Details) Sheet http://www.amerityre.com/role/NOTE4CAPITALLEASEDetails NOTE 4 - CAPITAL LEASE (Details) Details http://www.amerityre.com/role/NOTE4CAPITALLEASETables 20 false false R21.htm 020 - Disclosure - NOTE 4 - CAPITAL LEASE (Details) - Schedule of Capital Leased Assets Sheet http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable NOTE 4 - CAPITAL LEASE (Details) - Schedule of Capital Leased Assets Details http://www.amerityre.com/role/NOTE4CAPITALLEASETables 21 false false R22.htm 021 - Disclosure - NOTE 5 - STOCK TRANSACTIONS (Details) Sheet http://www.amerityre.com/role/NOTE5STOCKTRANSACTIONSDetails NOTE 5 - STOCK TRANSACTIONS (Details) Details http://www.amerityre.com/role/NOTE5STOCKTRANSACTIONS 22 false false R23.htm 022 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) Sheet http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) Details http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSTables 23 false false R24.htm 023 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Valuation Assumptions Sheet http://www.amerityre.com/role/ScheduleofValuationAssumptionsTable NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Valuation Assumptions Details http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSTables 24 false false R25.htm 024 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Stock Options, Activity Sheet http://www.amerityre.com/role/ScheduleofSharebasedCompensationStockOptionsActivityTable NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Stock Options, Activity Details http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSTables 25 false false R26.htm 025 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range Sheet http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range Details http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSTables 26 false false R27.htm 026 - Disclosure - NOTE 7 - LIQUIDITY (Details) Sheet http://www.amerityre.com/role/NOTE7LIQUIDITYDetails NOTE 7 - LIQUIDITY (Details) Details http://www.amerityre.com/role/NOTE7LIQUIDITY 27 false false R28.htm 027 - Disclosure - NOTE 8 - SUBSEQUENT EVENTS (Details) Sheet http://www.amerityre.com/role/NOTE8SUBSEQUENTEVENTSDetails NOTE 8 - SUBSEQUENT EVENTS (Details) Details http://www.amerityre.com/role/NOTE8SUBSEQUENTEVENTS 28 false false All Reports Book All Reports amty-20151231.xml amty-20151231.xsd amty-20151231_cal.xml amty-20151231_def.xml amty-20151231_lab.xml amty-20151231_pre.xml true true ZIP 47 0001185185-16-003641-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001185185-16-003641-xbrl.zip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end